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Extracellular Ca2+ ([Ca2+]ex) is increasingly recognised as an important messenger for 
intercellular communications. Recent evidence suggests that [Ca2+]ex plays a critical role in 
mediating the pulsatile insulin secretion from the pancreatic β cells, the impairment of which 
often represents an early pathological defect in the development of type 2 diabetes mellitus 
(T2DM). The underlying mechanisms for the latter remain to be elucidated, but are constrained 
by the lack of sensors suitable for the measurement of [Ca2+]ex in the extracellular environment. 
To enable the investigation on dynamic [Ca2+]ex and insulin secretion, two fluorescent 
indicators, Calcein and Rhodamine-5N (Rhod-5N), were systematically evaluated for 
measuring [Ca2+]ex. Under the optimised conditions, both of the two indicators showed robust 
fluorescent signals and high selectivity to [Ca2+]ex. Compared with previous studies, the 
fluorescence-based methods established for [Ca2+]ex in this thesis are easily accessible and 
inexpensive. Polydimethylsiloxane (PDMS) chip was then designed, fabricated and 
characterised to be capable of immobilising the biological tissues and manipulating their 
extracellular environment. Subsequently, a microfluidic sensing system was developed by 
integrating the optimised fluorescent indicator, microfluidic chip, laser-induced fluorescence 
(LIF) detection system and enzyme-linked immunosorbent assay (ELISA). The microfluidic 
sensing system, for the first time, enabled the simultaneous monitoring of the dynamic [Ca2+]ex 
and insulin concentrations in biological samples. The sensing system presented in this work 
can be used as a novel tool to gain fundamental insights as to how [Ca2+]ex is involved in the 
regulation of the pulsatile insulin secretion in both health and T2DM. The future work in this 
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Chapter 1   
 
The roles of Ca2+ in insulin secretion and the development 
of Ca2+ sensors for pancreatic islet study 
 
There is compelling evidence showing that both intracellular and extracellular Ca2+ signallings 
are coupled to insulin release from the pancreatic β cells, and are likely to be involved in the 
pathogenesis of β cell dysfunction and the progression of T2DM. Understanding of Ca2+ 
dynamics in relation to the endocrine function of the pancreatic islets has been predominantly 
facilitated by the development of Ca2+ sensing techniques and novel platforms (e.g. 
microfluidic devices). This chapter provides a comprehensive overview of the current 
understanding on: 1) the role of Ca2+ signalling in insulin secretion and the development of 
Ca2+ sensors for pancreatic islet study; 2) knowledge gaps in the understanding of the role of 
Ca2+ in insulin secretion; 3) the critical capabilities of Ca2+ sensors necessary for this area of 
research; 4) the rationale for the development of a sensing platform for simultaneous 
monitoring of Ca2+ and insulin. 
 
1.1 Background 
Diabetes is one of the most prevalent chronic diseases worldwide, affecting more than 400 
million people in 2014 (about 8.5 % of the adult population) 1 and resulting in over 827 billion 
USD direct medical expenditure 2. Over 90% of diabetes patients suffer from T2DM, which is 
commonly characterised as relative or absolute insufficiency of insulin secretion from the 
pancreatic β cells in the context of insulin resistance and, therefore, the elevation of blood 
glucose concentrations. Accordingly, tremendous efforts have been put into the understanding 
of the mechanism(s) underlying insulin secretion 3-5.  
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Among various regulatory factors, Ca2+ has been reported to account for both initial fast insulin 
release from the stored insulin granules within the β cells and the late-phase insulin synthesis 
and secretion 6. To this end, a number of tools have been developed for recording the dynamic 
changes of intracellular Ca2+. However, few sensing methods are established to monitor the 
[Ca2+]ex, which is likely to mediate intercellular communications and synchronising the 
secretive activity of individual β cells 7,8. Accordingly, development of a tool capable of 
simultaneous monitoring of [Ca2+]ex and insulin secretion from the pancreatic islets represents 
a critical step for improved understanding of insulin secretion in health and T2DM.   
 
1.2 Roles of Ca2+ signalling in insulin secretion  
Pancreatic islet, also known as the islet of Langerhans, is a group of organised endocrine cells 
(hormone-producing cells) in the pancreas, which contains approximately 106 islets 9. A 
pancreatic islet typically consists of three major endocrine cells, α cells (20%), β cells (70%) 
and δ cells (<10%), secreting glucagon, insulin and somatostatin respectively. As shown in Fig. 
1.1a & b, the cellular distributions and ratios of these endocrine cells differ substantially 
between mice and human. β cells are typically condensed around the core of a mouse islet (Fig. 
1.1b), while they are distributed globally within a human islet (Fig. 1.1a) 10,11. Although the 
differences in cellular distributions are substantial, pancreatic islets of different species exhibit 
a similar low level of basal insulin secretion at non-stimulatory blood glucose levels (< 3mM 
in human, < 6mM in mouse) and the stimulated insulin secretion as the glucose level increases 
3. Moreover, insulin secretions recorded from either isolated islets or from the peripheral 
circulation in humans, mice and dogs are pulsatile 12-20, with a typical frequency of ~5 minutes 
per pulse (Fig. 1.1e) 21. That the in vivo insulin curve pattern (corrected for amplitude) is 
coherent to that of the in vitro secretory bursts from individual islets suggests that the in vivo 
pulse is a reflection of coordinated secretion of insulin from different islets 22. Of note, the 
pulsatility of plasma insulin is diminished in patients with T2DM and their first-degree relatives 
23-25. The latter suggests that impaired pulsatility of insulin release may predispose to any 
substantial loss of  cells function in T2DM. Accordingly, the understanding of the 
mechanism(s) underlying the pulsatile secretion pattern of insulin and its impairment in 
patients with T2DM or individuals with high risks is of major clinical relevance to both the 





Figure 1.1 | The structural differences of pancreatic islets and the common pulsatility of insulin 
secretion observed in different species. a & b | Confocal images of pancreatic islets from a human and a 
mouse with immunostained for insulin (red), glucagon (green) and somatostatin (blue). (Scale bar = 50μm) 
11; c & d | Functional connectivity (FC) map indicating the distribution and connection strength of correlated 
β cells in an intact human and mouse islet during glucose stimulation. (Colour bar: 0 – 0.25 [blue] = lowest, 
0.76 – 1 [red] = highest) 26; e | The representative insulin releases pattern indicated by the insulin 
concentration in the circulating system with a frequency of 4~6mins in mammals 22. 
 
1.2.1 Intracellular Ca2+ signalling: a trigger of insulin secretion 
The secretion of insulin from pancreatic islets is coupled with glucose metabolism (i.e. the 
production of adenosine triphosphate, ATP), electrical excitation and intracellular Ca2+ 
signalling (Fig. 1.2). When blood glucose reaches stimulatory concentration, the increased ATP 
production in β cells leads to the closure of ATP-sensitive potassium channel (KATP channel) 
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27,28, which causes the reduction of the hyperpolarizing KATP current and induces a depolarizing 
current 29,30. The latter subsequently gives rise to the opening of voltage-gated Ca2+ channels 
(VGCC, also known as voltage-dependent Ca2+ channel, VDCC) 31. The influx of Ca2+ triggers 
the firing of action potential (at -50mV) and the fusion of insulin-containing granules with 
membrane for exocytosis 32. It is noteworthy that the secretion of insulin in response to an 
intravenous glucose challenge usually consists of two distinctive phases, an initial rapid phase 
(first phase) and subsequently slower and stable phase (second phase) 33. The first phase 
secretion is predominantly accounted for the readily release pool from the granules 31, while 
the second phase secretion results from the continuous insulin production in the β cells.   
 
 
Figure 1.2 | The Ca2+ signalling pathways in insulin secretion (left) identified by various Ca2+ probes 
in islet study (right). Left | Ca2+ signalling involved in glucose-stimulated insulin secretion (GSIS). The 
transport pathway of Ca2+ is indicated with black arrows. Abbreviation: GLUT, glucose transporter; Mito: 
mitochondria; MCU, mitochondrial Ca2+ uniporter; TCA cycle, tricarboxylic acid cycle; IP3R inositol 1,4,5 
trisphosphate receptor; ER: endoplasmic reticulum; SERCAs, sacro-endoplasmic reticulum Ca2+-ATPases. 
CaSR, Ca2+-sensing receptor. Right | Ca2+ probes used in islet study for identifying and monitoring the 





During the second phase, insulin is typically secreted in the pulsatile pattern 13,34. While the 
mechanism(s) underlying this phenomenon has not been fully understood, the intracellularly 
distributed Ca2+ has been regarded as the major driving factor, including cytoplasmic Ca2+ 
([Ca2+]c), mitochondrial Ca
2+ ([Ca2+]mito) and endoplasmic reticulum Ca
2+ ([Ca2+]ER) 
33,35,36. The 
[Ca2+]c directly facilitates the fusion of insulin-containing granule with the cell membrane. As 
a result, [Ca2+]c in the β cells have been observed to oscillate in parallel with the secretion of 
insulin from the isolated islet of mice and humans 37-40. Moreover, limiting the rises in [Ca2+]c 
by removing extracellular Ca2+  or blocking the VGCC attenuates the glucose-stimulated insulin 
secretion (GSIS) 41, further suggesting the direct effect of [Ca2+]c on GSIS. 
[Ca2+]mito and [Ca
2+]ER also oscillate in pace with [Ca
2+]c during GSIS 
42-46 and participate in 
the regulation of insulin secretion by modulating the ATP production and [Ca2+]c, respectively. 
In response to glucose stimulation, when [Ca2+]c increases, the mitochondria stores more Ca
2+ 
through the mitochondrial Ca2+ uniporter (MCU) 44,47. The increased [Ca2+]mito facilitates the 
production of ATP 48-51, which provides energy for insulin synthesis and secretion. It has been 
shown that silencing MCU by utilising small interference RNA 52 or buffering the Ca2+ in the 
mitochondrial matrix space 53  attenuates insulin secretion at the second phase 54,55. Meanwhile, 
endoplasmic reticulum (ER) recruits Ca2+ through sacro-endoplasmic reticulum Ca2+-ATPases 
(SERCAs) 56,57, followed by a slow release of Ca2+ at end of the oscillatory period. As a result, 
silencing SERCA3 or blocking SERCA channels gives rise to amplified [Ca2+]c oscillation and 
(hence) insulin secretion 56,58.  
By applying fluorescent Ca2+ probes, the dynamic variations of [Ca2+] in each compartment of 
β cells have been successfully tracked from glycolysis to insulin secretion. However, the 
observations hitherto have not identified the intrinsic pacemaker for glucose-induced [Ca2+] 
oscillation. Likewise, it remains unclear as to the relative importance of each component to the 
maintenance of  cell function. Nonetheless, the virtually identical insulin secretory pattern 
from purified β cells, isolated islets, and the whole endocrine pancreas suggests effective 




1.2.2 Extracellular Ca2+ signalling: an integrator of secretion 
Due to the differences in cellular distribution and composition, the mechanisms underlying the 
intercellular communication would intuitively be expected to vary between mice and human 
islets. In mice, β cells are electrically connected by gap conjunctions (GJs), which spread the 
membrane depolarisation and thereby transmit the stimulatory signals between the 
neighbouring β cells for the synchronised secretion action 59. In this way, β cells in mice islets 
display a high strength of correlation during GSIS (Fig. 1.1d). The disruption of GJs impairs 
both synchronised [Ca2+]c oscillation and glucose-induced pulsatile insulin secretion 
60,61. As 
discussed above, the mechanism of GJs in mice predominantly influences adjacent β cells. By 
contrast, human islets have a much weaker cellular network (Fig. 1.1c), such that the function 
of GJs would be limited or ineffective. In humans, the diffusible factors, including extracellular 
Ca2+, neurotransmitter 62, intra-islet hormones and gut-derived incretin hormones 26, are often 
considered for intra- and inter-islet communication and coordination.  
[Ca2+]ex is recently reported to mediate intercellular communication through the extracellular 
Ca2+-sensing receptor (CaSR) 63. CaSR was initially found to be the regulator for serum Ca2+ 
concentrations in the body. When the [Ca2+]ex fluctuates in the local environment, CaSR senses 
the local [Ca2+] and regulates parathyroid hormone secretion to adjust serum Ca2+ 
concentrations 64. More recently, the CaSR sensing pathway has been suggested to account for 
intercellular communication 63. In an ex vivo model, Hofer, M. A. et al. co-cultured non-CaSR-
expressing BHK-21 cells as ‘donors’ with CaSR-expressing HEK293 cells (HEK-CaSR) 
(‘sensor’). They observed that the agonist-induced [Ca2+]c changes in the ‘donor’ cells 
generated a Ca2+ extrusion, which could be detected by the nearby ‘sensor’ cells and further 
triggered the alterations in [Ca2+]c of ‘sensor’ cells. This propagation of [Ca
2+]c signal is CaSR-
dependent, indicating the intercellular communication could be achieved by local [Ca2+]ex-
activating CaSR 65. Accordingly, by using the specific fluorescent probe, a rise of local [Ca2+]ex 
was observed when CaSR was activated. The rise in [Ca2+]ex could further activate the CaSR 
expressed on the neighbouring cells 66. 
As the Ca2+ is co-released with insulin from the secreting-granules, [Ca2+]ex in the intercellular 
space has been shown to increase in response to glucose stimulation 67. Activation of CaSR by 
Ca2+ (e.g. 10 mM) increases the insulin secretion from both MIN6 pseudoislets 68 and human 
islets 69 – such effect attenuated when [Ca2+]ex is removed 
69. Moreover, stimulating insulin 
secretion through this pathway can be independent of glucose, leading to the secretion of 
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insulin from the cells that have not been exposed to glucose. In addition, activation of CaSR 
up-regulates the expression of VGCCs, which could further augment the GSIS 70. Given the 
abundant expression of CaSR on both mouse and human β cells 68,71,72, the CaSR-signalling 
pathway has been proposed to coordinate insulin secretion within islets 73, where [Ca2+]ex might 
serve as a potential synchroniser of insulin secretion 74. However, due to the lack of an effective 
sensing tool for tracking [Ca2+]ex, it remains unclear on how [Ca
2+]ex changes in the interstitial 
fluid and whether it indeed synchronises the pulsatile insulin secretion in intact human islets.  
 
1.3 Development of Ca2+ sensing techniques in secretion analysis 
The study concerning the roles of Ca2+ in insulin secretion can be dated back to 1966, when 
the presence of Ca2+ in the extracellular environment was recognised as a prerequisite for 
insulin secretion from the pancreatic β cells 75. In the next year, the luminescent protein 
aequorin (Aeq) isolated from jellyfish was firstly reported to reliably record the fluctuations of 
intracellular Ca2+ 76. The last 50 years have witnessed a rapid evolution of Ca2+ sensing 
techniques and how they have advanced the understanding of Ca2+ signalling in the biology of 
pancreatic islets. The timeline below summarises the milestone events relating to the 
development of advanced sensing techniques (including the emergence of both new-generation 
sensors and functional sensing platforms) and the progressive understanding of Ca2+ signalling 
pathways underlying insulin secretion. 
 








1.3.1 Synthetic fluorescent Ca2+ indicators 
With a large available tool library, synthetic fluorescent Ca2+ indicators are currently the most 
widely used Ca2+ sensing tools in islet study (selected indicators for islet study are summarised 
in Table 1.1). These Ca2+ indicators typically consist of three components: fluorophore, Ca2+ 
chelator and linker. While the fluorophore accounts for the changes in fluorescent signals, the 
Ca2+ chelator recognises and interact with Ca2+ and, therefore, determines the sensitivity and 
selectivity of the indicators. To reflect the change in Ca2+ concentration ([Ca2+]), the interaction 
between Ca2+ and chelator induces the changes of fluorescent signals of the fluorophore in 
response to the fluctuation of [Ca2+]. In terms of ion indicators, there are generally four 
mechanisms underlying the fluorescent processes, including photo-induced electron transfer 
(PET), internal charge transfer (ICT), formation or disappearance of excimer and Förster 
resonance energy transfer (FRET) 77. This section focuses on PET and ICT (FRET in the next 
section), as these mechanisms are predominantly used to develop fluorescent Ca2+ probes. 
In the processes of PET and ICT, the Ca2+ binding-induced electron movement is the key trigger 
of the fluorescent signal switch.  For PET-based off-on indicators, the electron-rich chelator is 
spatially separated from the fluorophore by a linker (on-off PET indicator is not commonly 
used in Ca2+ sensing, details can be found in another review 78). On excitation of the fluorophore, 
an electron of the highest occupied molecular orbital (HOMO) is excited to the lowest 
unoccupied molecular orbital (LUMO). The PET from the Ca2+-free chelator competes with 
the relaxation of the excited electron of the fluorophore and therefore quenches the 
fluorescence intensity of the excited fluorophore (Fig. 1.3a, i). When bound to Ca2+, the redox 
potential of the chelator increases, leading to lower HOMO energy (less likely to remove an 
electron from the orbital). Thus, PET-induced fluorescence quenching is inhibited and the Ca2+ 
concentration will be indicated by the enhancement of the fluorescence intensity (Fig. 1.3a, ii). 
For example, when excited by at 488nm, Fluo-3 display significant fluorescence enhancement 











































Quin-2 1, 6 60nM 355 330 495 495 5-8 a. 80,81 
Fura-2 1, 2, 3, 4 224nM 363 335 510 505 (13-25) b. 36,38,82-85 
Indo-1 2 230nM 346 330 475 400 (20-80) c. 86 
Fura-PE3 2 250nM 364 334 508 500 (18) d. 87,88 
Fluo-3 4 390nM 503 506 525 525 40-100 e. 89 
Fura-red 1,2, 4, 5 140nM 470 435 660 660 (5-12) f. 90-92 
Apart from the journal references given in the table, the data above is also referred to The Handbook: A Guide to Fluorescent Probes and Labeling Technologies (11 
ed.) by Molecular ProbesTM 79. Kd, the dissociation constant of indicator; Ca2+ free, no Ca2+; Ca2+ bound, binding occurred between indicator and Ca2+; Fmax/Fmin, the 
ratio of maximum fluorescence to minimum fluorescence of indicator; Rmax/Rmin, the  ratio of maximum fluorescence ratio to minimum  fluorescence ratio 
Subjects: 1. Isolated mouse β cells 
 2. Intact mouse islet 
  3. Isolated human β cells 
  4. Intact human islet 
  5. MIN6 β cells (highly differentiated and glucose-responsive murine β cell line) 93 
  6. Clonal insulin-releasing cell line RINm5F 
Note:      a. Quin-2: The first generation of fluorescent Ca2+ indicators. Both the absorption coefficient and the quantum efficiency are relatively low for Quin-2 in  
                   comparison to later developed fluorescent indicators 94,95. 
  b. Fura-2: A ratiometric indicator by dual-excitation (340/380nm). High compartmentalisation and strong binding to proteins. 
  c. Indo-1: A ratiometric indicator with dual emissions (405/485nm) and high affinities for Zn2+ and Mg2+. 86 
  d. Fura-PE3: Derivative of Fura-2, designed for leakage resistance from the cytoplasm, high Ca2+-induced fluorescence change.  
  e. Fluo-3: Enhanced fluorescence with visible excitation light 89.   
  f. Fura-red: A ratiometric measurement by dual-excitation (420/480nm). A long emission wavelength in the red spectrum, compatible with other ion-sensitive   
     fluorescent indicators for multiplexing measurement. 
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Unlike the three components of the PET sensing system, where the electron donor and acceptor 
are charged-separated, the electron transfer in the ICT-based indicators occurs within an 
integrated electronic system as the two components are conjugated. As we see in Fig. 1.3b, i, 
an electron donor (e.g. dialkylamino-) and an electron acceptor (e.g. carbonyl) is attached to 
the two sides of the fluorophore respectively. Then, an ion chelator is integrated into the donor- 
or acceptor-side of the fluorophore. The introductions of electron donor and acceptor induce 
the polarisation of the ᴨ-electronic system, leading to the change in the intermolecular 
interaction between the fluorophore and the surrounding environment. For both ground and 
excited state of the fluorophore, its energy is affected by the degree of the interaction with the 
local environment, where a stronger intermolecular interaction, such as intermolecular 
hydrogen bonding 96, resulting in a lower energy scale and, therefore, a spectral shift to a longer 
wavelength, vice versa (Fig. 1.3b, ii). When the Ca2+ chelator is integrated into the indicator, 
the presence of Ca2+ modulates the polarity of the electronic system, depending on which 
electron group is bound to Ca2+. For example, the binding of Ca2+ to the chelator (donor) of 
Fura-2 suppresses the electron-donating effect of the donor group, leading to a lower polarity 
of the molecule and, therefore, a reduced intermolecular interaction. As a result, the excitation 
wavelength shifts from 490nm to around 430nm and excitation wavelength-ratiometric 
measurement is achieved by collecting the ratio of the excitation intensities at these two 
wavelengths (Fig. 1.3b, iii) 79. There are also indicators enable emission wavelength-ratiometric 
measurement, such as Indo-1.       
The selection on either an intensity-based or ratiometric indicator requires to consider the aims 
of the study and accessible facilities in a specific scenario. For non-ratiometric indicators 
(intensity-based), the binding of Ca2+ causes concentration-dependent changes in fluorescence. 
Upon a certain excitation light, fluctuations in Ca2+ are reflected by the dynamic fluorescence 
intensities at a fixed emission wavelength. Thus, the task of monitoring Ca2+ through the 
intensity-based indicator can be accomplished by a simple spectrometer system, for which both 
excitation and emission light can be delivered and collected with the wavelength of interest. 
However, non-ratiometric indicators are not suitable for a quantitative study. Firstly, the optical 
signal strength of these indicators varies in different concentrations of indicators as well as the 
excitation conditions. Given that it is difficult to precisely identify the indicator’s concentration 
within the cells, it would cause significant errors when correlating the observed fluorescence 
intensity with [Ca2+]. Moreover, the leakage and photobleaching of the molecular dyes 
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undermine the prediction on the cellular [Ca2+] via reading out fluorescence intensity scales. 
By contrast, the ratiometric indicators are featured with the capability of self-calibrating the 
recorded signals in ratio instead of only acquiring the absolute fluorescence intensity. Therefore, 
ratiometric indicators remove the interferences caused by the aforementioned factors: indicator 
concentration, indicator leakage, heterogeneous distribution, weak fluorescent signals and 
different optical settings.  
 
 
Figure 1.3 | Fluorescent principles and signal spectra of the synthetic fluorescent indicator. a | 
Fluorescent principle and example of fluorescent indicators based on PET: i | Schematic of Ca2+ binding-
induced fluorescence enhancement via suppressing PET; ii | The fluorescent signal of PET-based indicator 
is the change in fluorescence intensity without spectral shift; iii | Fluorescence emission spectra of  Ca2+  
indicator, Fluo-3, which is based on PET 79; b | Fluorescent principle and example of internal charge transfer 
(ICT) -based fluorescent indicators: i | Schematic of Ca2+-binding modulates ICT, where the position of 
Ca2+-binding chelator could  exert the opposite effect on the ICT. When the chelator links to the charge 
donor (negatively charged), the binding of Ca2+ suppresses the electron transfer from the donor to acceptor; 
on the contrary, the Ca2+-binding with the chelator linked to the acceptor will enhance the internal electron 
transfer; ii | The reduced charge transfer leads to a blue shift of fluorescent spectrum, while the enhanced 
charge transfer results in a redshift; iii | Excitation spectra shift of an ICT-based fluorescent indicator, Fura-
2 79. 
 
Apart from the fluorescent mechanism, dissociation constant (Kd) of the indicator is also 
essential when determining the proper fluorescent indicator. As an intrinsic feature of chelator, 
Kd reflects the interaction between the recognition/binding unit and target ligand at equilibrium 
which therefore defines the effective range of an indicator capable of sensing 95. Based on the 
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mass action law, a target concentration of 0.1~10 Kd is considered as the analytically practical 
range for a monovalent reversible binding. This is because that in the range of 0.1~10 Kd 
concentration, approximate 20 – 80% of the indicators are bound and the fluorescent signal of 
these bounded indicators show a relatively linear response to the change of target ions 97. It 
demands that indicator with appropriate Kd be considered for varying studies targeting at 
different concentrations of ions. For example, in isolated islets, the glucose-induced [Ca2+]c 
fluctuations were firstly recorded by Quin-2. In this experiment, it was observed that the 
glucose stimulates an initial decrease of [Ca2+]c, followed by a marked increase in [Ca
2+]c 
80. 
However, as the upper limit of Quin-2 in sensing Ca2+ is around 600nM (~10×Kd, Table 1.1) 
and [Ca2+]c in β cells fluctuates between 40 and 1000nM, Quin-2 was not the optimal indicator 
for monitoring [Ca2+]c, particularly for the higher [Ca
2+]c. To accurately monitor [Ca
2+]c, the 
synthetic fluorescent Ca2+ indicators with both larger Kd of 100-400nm and a higher optical 
strength were developed (Table 1.1). Furthermore, Ca2+ indicators with even higher Kd (e.g. 
Rhod-2) were developed to monitor [Ca2+] in organelles, where [Ca2+] could be at much higher 
concentrations than it in the cytoplasm. 
As discussed earlier, the secretion of insulin from the pancreatic islets involves multiple, 
dynamic regulatory pathways. A complete understanding of these complex processes relies on 
concurrent monitoring of multiple factors, including [Ca2+] in different compartments and other 
regulatory factors involving in the process. The expanding pool of fluorescent indicators with 
varying spectral features render the multiplexed sensing in a single experiment. As illustrated 
in Table 1.2, the multi-targets measurements have been advancing the understanding of the 
signalling and regulatory pathways in dynamic insulin release. In parallel, the development of 
multiplexed sensing work poses increasing demand on new-generation sensing platforms to be 
compatible with the multiple sensing techniques, thereby simplifying the experiment 
operations, minimising the undesired interference, and picturing the image towards 









Table 1.2 | Multi-targets monitor in insulin secretion study 
Targets Indicators Findings 
1. [Ca2+]c Fura-red 1. Slow oscillatory islet respiration induced by glucose depends on 
the interaction between ionic and metabolic events in β cells, which 
potentially comprise the pulsatile insulin secretion 90.  
2. NADH Auto-fluorescence 
3. MMP Rh123 
1. [Ca2+]c Fura-red 1. Glucose-induced cytoplasmic ATP oscillation negatively 
regulated by [Ca2+]c;  
2. The interaction between ATP and [Ca2+]c underlying the pulsatile 
insulin secretion 98.  
2. ATP Perceval 
3. pH BCECF 
1. [Ca2+]c Fura-2, Fura-red 1. Glucose induces the cyclic adenosine monophosphate (cAMP) 
oscillation in β cells, which regulates the pulsatile insulin secretion 
92;  
2. [Ca2+]c enhances the cAMP oscillation, suggesting a Ca2+-
independent pathway for regulating insulin secretion 99.  
2. cAMP Translocation 
protein indicator 
     *MMP, mitochondrial membrane potential. 
 
The ever-evolving synthetic Ca2+ indicators are highly successful in monitoring Ca2+ in 
different pathways, but several inherent drawbacks of these indicators are noted. Firstly, for 
UV-excited indicators, the photobleaching is unavoidable. A severe fluorescence intensity drop 
was observed for the indicators under UV light exposure as short as 5 minutes 100, preventing 
the long-term real-time tracking the ions of interest 107. Since photobleaching might occur at 
various wavelengths to different extents, the UV-excited ratiometric indicators become 
inaccurate for quantitative measurement 101. Secondly, the exposure of cells or tissues to UV 
lights may affect their biological functions adversely. For example, the proportion of Ca2+ 
oscillation in β cells was substantially diminished after exposure to UV light for 30 minutes 38. 
Although the Vis-excited Ca2+ indicators would circumvent the aforementioned issues caused 
by the UV light excitation, only a handful of such indicators have been developed, with limited 
Kd options and non-ratiometric fluorescent properties. Notably, both UV- and Vis-excited Ca
2+ 
indicators are unable to be localised and retained around the targeted organelles and are 
therefore not suitable to monitor subcellular Ca2+. Moreover, the by-products during the 
acetoxymethyl (AM) ester-assisted loading process, including formaldehyde and acetic acid, 
are potentially toxic and may impair insulin secretion from the β cells or islets. Finally, 
synthetic Ca2+ indictors commonly confront pitfalls including compartmentalisation, leakage, 




1.3.2 Protein-based Ca2+ indicators 
Originated from Aequorea Victoria jellyfish, protein-based Ca2+ indicators are classified as 
luminescent protein indicators and genetically encoded Ca2+ indicators (GECIs), represented 
by aequorin and green fluorescent protein (GFP), respectively. Historically, the bioluminescent 
Ca2+-binding photoproteins were the first-generation indicators used for recoding intracellular 
Ca2+ changes via microinjection into cytoplasm 76,102. Although the indicators facilitated the 
early studies on the importance of neuronal events 103,104, the microinjection requests the 
invasive loading, which has restricted the indicators’ implementations on giant and robust cell 
types. In the 1990s, the renaissance of photoprotein aequorin was in line with the development 
of genetic engineering technology, permitting that recombinant aequorin was successfully 
expressed in mitochondria 95,105, which enabled the tracking of Ca2+ dynamics in the subcellular 
compartments. Soon after, the developed protein-based GECIs were put into the investigation 
of subcellular Ca2+ signalling. The early GECIs consist of two fluorescent proteins variants 
connected by a Ca2+-responsive peptide calmodulin (CaM), and a calmodulin-binding peptide 
M13 106. Compared with the bioluminescent photoprotein, GECIs have a number of the 
inherent advantages, including higher brightness, no cofactors requirement, etc. 107-109. 
The photoprotein aequorin is composed of an apoprotein apoaequorin and a chromophore, 
consisting of coelenterazine and oxygen molecule (Fig. 1.4a, i). In the presence of Ca2+, the 
binding of Ca2+ to the indicators induces the intramolecular oxidation of coelenterazine to 
coelenteramide. The coelenteramide is further released from aequorin. As the coelenteramide 
decays from excited to the ground state, the process is coupled with the emission of a photon 
110,111.  In the case of GECIs, there are three typical structures of these indicators: FRET-based 
GECIs, single-fluorophore GECIs and BRET-based GECIs. For FRET-based GECIs, the 
binding to Ca2+ induces the conformational changes of calmodulin and M13, which reduces 
the distance between the two fluorophores. FRET is subsequently permitted between the two 
fluorophores with a shorter distance, resulting in distinctive optical signal 112 (Fig. 1.4a, ii). For 
the single-fluorophore indicator, the conformational changes of the binding units alter the 
protonation state of the chromophore and (hence) the fluorescence intensity of the protein 107,109 
(Fig. 1.4a, iii). Similar to the FRET-based GECIs, bioluminescence resonance energy transfer 
(BRET) – based GECIs have also been developed, which consist of a photoprotein aequorin 





Figure 1.4 | Schematic of viral transfection loading and sensing principles of representative GECIs. a 
| Fluorescent principle of representative GECIs: i | In the presence of Ca2+, aequorin undergoes internal 
oxidation of coelenterazine to coelenteramide, leading to the release of a coelenteramide and the emission 
of a photon of 470 nm. The re-functionalisation of aequorin requires the supplement of coelenterazine; ii | A 
GECIs based on FRET typically consists of a CFP, a YFP, a CaM (linker in “black”) and a CaM-binding 
peptide M13 (linker in red). The Ca2+ binding-induced conformational changes CaM and M13 lead to a 
reduced distance between CFP and YFP. As a result, the fluorescence decreases in CFP while increases in 
YFP due to the increased FRET; iii | A representative example of GECI based on single GFP, where the 
binding of Ca2+ induces the conformational changes of CaM and M13. Such conformational changes affect 
the absorption spectra or fluorescence quantum yield of the fluorophore, which further displays an enhanced 
or decreased fluorescence intensity; iv | A single GFP can also be connected with aequorin. In the presence 
of Ca2+, the fluorescence emitted by aequorin can excite the GFP via BRET. Therefore, the BRET-based 
GECIs enable the fluorescent measurement without an external light source; b | Schematic of viral 
transfection loading of GECIs into target cells. The vector virus carrying the fusion recombinant gene 
transfects the host cell and releases fused DNA into the host cell. With the help of integrase, the indicator 
DNA was integrated into the host gene and subsequently expressed in the target compartment after DNA 
transcription and mRNA translation. 
 
Unlike the synthetic chemical indicators, which suffer from the inaccurate localisation and poor 
retainment of the indicators in the targets of interest over time 116,117,118, GECIs can be precisely 
localised in a target area through viral vectors introduction. Briefly, the cDNA sequence of the 
protein indicators is fused with a tag sequence from the target compartment. The encoded genes 
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are then integrated into the host DNA with the assistance of integrase of the vector.  Depending 
on the origin of the tag sequence, the indicator is expressed in a specific compartment (Fig. 
1.4b). When recombinant aequorin was first time introduced into insulin-secreting cells, 
glucose-induced oscillations of [Ca2+]mito were recorded in MIN6 cell line and isolated rat islets 
42,119. To date, a number of GECIs have been utilised in islet study and are becoming essential 
tools for understanding the dynamic [Ca2+] in the subcellular compartment (Table 1.3). 
From the first intracellular Ca2+ recording to the measurements of subcellular Ca2+, the 
development of protein-based Ca2+ has facilitated the understanding of the microdomain Ca2+ 
signalling underlying biological events. Nevertheless, protein-based indicators have several 
limitations. For example, bioluminescent protein, although it does not require external 
excitation light, is not suitable to be used in the small or single-cell study. This results from the 
low light quantum yield of such protein 120, leading to a weak fluorescent signal. Another 
drawback concerning the application of aequorin is the requirement of cofactor coelenterazine 
in the culture medium to re-functionalise the aequorin after oxidation. For GECIs, they suffer 
from high sensitivity to pH and low fluorescence intensity 95,121. Although cytosolic pH is under 
tight control in normal conditions, the pH fluctuations can still take place in response to 
inflammation and in the process of programmed cell death 122. Additionally, the optical signal 
strength of protein indicators is often much smaller compared with that of chemical indicators. 
By comparing the Table 1.1 and Table 1.3, it shows that Fmax/Fmin or Rmax/Rmin of most protein-
based Ca2+ indicators is < 10 (Table 1.3), while those of synthetic Ca2+ indicators are generally 















Table 1.3 | Fluorescent properties of protein-based Ca2+ indicators in islet research 
Protein Version Cell 
Type 





Aequorin recombinant  1, 3, 4 mito 0.2-50 / /  a 42,95,123 
Pericam 2mt8RP 2 mito 1.7 415/490  535 (10) b 44,55,124 
Cameleon Ycam-4ER 4 ER 100-1000 440 535/480 (1.4) c 125,126 
Cameleon D4ER 2 ER 65 435 540/475 (3.8) a 56,127 
 
Subject: 
1. INS-1 (insulin-secreting insulinoma cell line) 
2. Isolated mouse β cells 
3. MIN6 β cells 
4. RINm5F cell lines 
 
Note: 
a. Recombinant aequorin: The low photon emission limits the application of aequorin on cell population study, requiring high sensitivity photomultiplier and 
amplifying the process. By combining it with Fura-2, the [Ca2+]c and [Ca2+]mito can be measured in parallel. 
b. Pericam: It provides a ratiometric measurement. Simultaneously detect the [Ca2+]mito, [Ca2+]c and [ATP/ADP]c with a combination of Fura-red and Perceval 
c. Cameleon: Ycam-4ER has a low Ca2+ affinity and ratio-metric feature. Thus it is suitable to be used in a compartment with a high [Ca2+] like the ER. 
d. Cameleon: Compared with Ycam-4ER, D4ER has a higher affinity to Ca2+ and the fluorescence intensity on Ca2+ binding.
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1.3.3 Ion-selective microelectrode (ISM) 
Based on the conventional microelectrode, which was used for measuring cell membrane 
potentials, resistance and net ion transport, the development of ISM has enabled the recording 
of specific ion flux across the membrane 128. In principle, ISM converts the electrical currents 
relating the variations in specific ion concentrations into amplified dynamic electrical voltage 
signals. Typically, the ISM kit is composed of a sensing and a reference electrode, an amplifier 
and a voltmeter. In a liquid membrane ISM (Fig. 1.5a), the tip of the measuring electrode is 
filled with ion-selective ionophore (represented by ion carriers in membrane ISM) followed by 
internal electrolyte 129, while the reference electrode contains electrolyte like KCl. The 
ionophores reversibly bind to target ions and transport the ions from the aqueous sample 
bathing the microelectrode to the electrolyte within the microelectrode. The process of ion 
transport alters the electrochemical equilibrium of the electrolyte, leading to a variation in the 
potential between measuring and reference microelectrode. Accordingly, the ion concentration 
can be calculated based on the amplified voltage, which is proportional to the logarithm of the 
target ion activity. To date, a wide range of the ion-selective ionophores has been developed 
and measured with ISM for a number of ions, including Ca2+, Na+, K+, H+, Cl- et al.  
Compared with synthetic fluorescent indicators, the ISMs offer broader sensing range and 
longer measurement duration. For fluorescent Ca2+ indicators, they generally respond to [Ca2+] 
from nano- to micromole, while Ca2+-selective microelectrodes (CSMs) shows the linear 
responses to [Ca2+] ranging from 10-7.5 to 10-1M 130; the latter fully cover the dynamic range of 
[Ca2+]c as well as [Ca
2+]ex. The ISMs are free from photobleaching and diffusion, which enables 
a stable and long-term recording of [Ca2+]ex by being statically implanted in the extracellular 
fluid. Thus, the ISMs have been successful in revealing the dynamic [Ca2+]c and [Ca
2+]ex in a 
variety of biological setups, including neural tissue 131,132, bone fragment 133, cardiac muscle 
134, gastric mucosa 135 as well in islet study 67,136,137. 
The first application of ISM on islet study dates back to 1986, when Perez-Armendariz and 
Atwater measured [Ca2+]ex around β cells of a mouse islet with CSM 
136. They found that a 
0.5mM depletion in [Ca2]ex was induced by 11mM glucose stimulation and the [Ca
2]ex returned 
to basal level followed by this depletion; the reversible fluctuations repeated during the 
measurement. Although the measurement only lasted for ~1 minute, the results, to a certain 
degree, projected the profile of fast oscillatory activity of Ca2+ under stimulation. Similar 
depletion of Ca2+ efflux stimulated by the same glucose concentration was observed when 
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Moura, A. implanted the microelectrode tip nearby the cytoplasm membrane in β cells. Efflux 
of Ca2+ rose back but oscillated in phase with the membrane potential. The oscillation pattern 
ceased immediately as the glucose stimulation was removed 137. However, as the measuring 
microelectrode was impaled within the cytoplasm membrane, the oscillatory pattern was more 
likely to be attributed to the dynamic [Ca2+]c fluctuations induced by glucose rather than the 
result of dynamic [Ca2+]ex. The most recent and reliable [Ca
2+]ex measurement in islet study 
was conducted by Gerbino, A. et al, in which CSM was positioned in the intercellular cavity 
within the INS-1E pseudoislet (PI) (Fig. 1.5b) 138. The glucose-evoked [Ca2+]ex reduction was 
confirmed in this study. Moreover, a significant increase in [Ca2+]ex was observed following 
the reduction, suggesting that insulin secretion from granules alters local [Ca2+]ex. However, as 
the electrode was set in a relatively restricted space, its position may affect the response time 
and sensitivity (amplitude), which blurs the spatial and temporal resolutions.   
As discussed in section 1.2.2, [Ca2+]ex plays a critical role in mediating intercellular 
communication and synchronising β cells and islet activities for the pulsatile secretion of 
insulin. Therefore, the robust detection of both [Ca2+]ex and the pulses of insulin secretion is 
intriguing. Though currently employed Ca2+ sensing techniques allow to picture the transient 
Ca2+ events within the islets, correlation of the varying interstitial [Ca2+] with insulin secretion 
utilizing the currently available sensors remains an extremely challenging task (Table 1.4). The 
interstitial [Ca2+] is at the concentration of ~1.2mM, which is over three orders magnitude 
higher than the [Ca2+]c 
139. At this level of Ca2+, fluorescence-based indicators are generally 
saturated and would, therefore, be problematic to show genuine dynamics of interstitial [Ca2+] 
by monitoring the fluorescence changes, unless the [Ca2+] is intentionally maintained at an 
unrealistic low level. However, the latter setting misses the true events in vivo, so that the 
relevance and significance of the results are limited 74. In terms of ISM, the protocol is only 
effective in recording the Ca2+ activity around the detection tip, typically limited around 1μm, 





Figure 1.5 | Sensing principle and applications of ISM in islet study. a | Schematic of the ISM tip structure 
and sensing mechanism. The ionophore at the tip of the detection probe can reversibly convert the ions from 
the working environment to the inner electrolyte 129. As the ionic component changes in the electrolyte, the 
potential varies between the detection probe and reference probe, which contains solution such as KCl 
without ionophore. The changes in the target ion concentration will be read out by a voltage meter; b | 
Illustration of the placement of ISM tip in measuring [Ca2+]ex of INS-1E pseudoislet 138. Optical microscope 
image shows a double-barrelled selective microelectrode in the proximity of the PI (left). Scale bar, 100μm. 
A confocal microscopy picture exhibits an entire PI stained by BCFCF (green) and Hoechst (blue), showing 
the cytoplasm and nuclei respectively (right). The white triangles point out the cavity for positioning the tip 
of ISM; c | The Ca2+ changes in the intercellular space within an INS-1E pseudoislet in response to 20mM 
glucose (left). Time course of dynamic [Ca2+]ex under 20mM glucose stimulation (right). 
 
In order to probe [Ca2+]ex at multicellular or tissue-level, such as intra-islet [Ca
2+]ex, the sensors 
are expected to be capable of : (i) generating signal changes in response to sub-millimolar Ca2+ 
fluctuations in the high background of intra-islet Ca2+ (1mM); (ii) correlating multicellular 
[Ca2+]ex with the dynamic insulin secretion, instead of the localised measurement; (iii) 
measuring the Ca2+ dynamics in a highly preserved in vivo secretion conditions. In this regard, 
there is no established method that is capable of distinguishing the small fluctuations of [Ca2+]ex 
in the context of high background and, in the meantime, correlating the dynamic [Ca2+]ex with 
the insulin secretion. Fortunately, the fast-evolving microfluidic devices are being a promising 









Table 1.4 | Summary of Ca2+ sensors for islet studies 
  
Synthetic indicator 
Protein-based probes  
ISM Recombinant Aeq GECIs 
Interest of sensing Cytosolic Ca2+ Endoplasmic reticulum and mitochondria Ca2+ Extracellular Ca2+ 















Loading method AM-ester loading Plasmid transfection Physical implantation 
Kd 0.06 – 0.39μM 79 0.2 – 50μM 144,145 1.7 – 1000μM 95,146 10-4 – 102μM 147,148 





- ratiometric measurement 
- high S/N ratio 
- large available library  
- biocompatible loading method 
- no excitation required 
- non-photobleaching 




- precise localisation to 
targets 
 
- stable electrical signal reading 





- photobleaching  
- interference by other metal ions   
- cytotoxicity concerns 
- compartmentalisation  
- non-ratiometric 
measurement 
- ultralow emission intensity 
- transfected loading via viral 
vector 
- pH-sensitive spectrum 
- photobleaching 
- transfected loading via 
virus vector 
- limited to electrode point (no 
mapping)  
- complicated calibration 
- longer response time 
 
S/N, signal to noise ratio. The fluorescent indicators generally show linear fluorescence changes to Ca2+ ranging from 0.1 × Kd to 10 × Kd; [Ca2+] refers to 
the Ca2+ concentration in each compartment of pancreatic β cells  
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1.4 Microfluidic devices for secretion analysis 
With the increasing demands in the physiological relevance of experimental setup, dynamic 
control on the cell culture environment to well mimic in vivo scenarios is emerging as a 
fundamental requirement in the biological study, which can hardly be achieved by traditional 
culture techniques. The conventional cell culture is generally conducted in a flat cell culture 
dish/plate, where cells are statically immersed in the cell culture medium. The changes in cell 
culture environment are achieved by manually replacing the medium or supplementing specific 
stimulus into the medium. Therefore, conventional cell culture suffers from the inconvenience 
in sample manipulation. It is time/labour- consuming to achieve the physiological culture 
environment which changes dynamically in accordance with the in vivo conditions 149. 
Secondly, highly frequent sampling is required to monitor the dynamic secretory activity. This 
is not only a labour-intensive process, but also would change the cell culture environment as 
the medium is continuously collected from the well for analysis 150. Thirdly, it is extremely 
challenging to study the dynamic secretory interactions between cells or tissues by 
conventional culture method due to its static and isolated nature. To highly replicate the 
experimental culture as the in vivo conditions, the microfluidic devices based on microfluidic 
perfusion system (MPS) are emerging as invaluable tools for investigating the fingerprint of 
islet secretion 151,152.  
The microfluidic devices designed for islet secretion analysis typically consist of three key 
components, including perfusion controller, cell/tissue culture chamber and analytical 
apparatus (Fig. 1.6a) 153. The perfusion controller is used to manage the flow rates and dynamic 
gradients of the purpose-designed medium that is applied to cultured islets in the chamber. 
Therefore, the constant flow of culture medium not only provides the necessary refreshing 
nutrients for maintaining cell viability, but also dynamically controls the stimulatory 
components in the extracellular environment. To evaluate the islet function under hypoxia 
condition, Eddington, D. T. et al. designed on-chip MPS with the capability to adjust the 
oxygen content in the microenvironment of islets 154,155. Following the same principle, Roper, 
M. G. et al. successfully manipulated the dynamic glucose delivered to islets, with manageable 
amplitude and periodicity 156-158. As the perfusion fluid is pumped into the culture chamber, the 
insulin level in the flowing samples is a dynamic indicator of the secretion activity of β cells 
or intact islet. To stabilise the cells/tissues in a flowing condition, four trapping mechanisms 
are currently applied on MPS in islet studies, including dam-wall like traps (Fig. 1.6b, i) 159,160, 
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tissue nozzle (Fig. 1.6b, ii) 161, U-shape cups islet arrays (Fig. 1.6b, iii) 162 and circular wells at 
the bottom of a chamber (Fig. 1.6b, iv) 163. A recently designed microfluidic device is capable 
of mounting up to 100 islets 162. However, the limitation of applying MPS is the longevity of 
the culturing pancreatic islets isolated from the pancreas. So far, the maximum culture period 
in microfluidic device lasts up to 48 hours, which is much shorter than the in vitro culture of 
primary cells (a few weeks) 164.  
 
 
Figure 1.6 | Schematics of general MPS set up and tissue trapping mechanism for islet study. a | A 
typical microfluidic set up for pancreatic islet study; b | Representative mechanisms for tissue immobilisation: 
i | Dam wall-like islet trap in microfluidic chips for simultaneous monitoring for [Ca2+]c and insulin secretion 
159,160; the electro-osmotic flow (EOF) channel shows the pathway of samples for insulin quantification;  ii | 
Nozzle-like traps in a microfluidic chip for highly efficient viral transduction of pancreatic islets 161. The 
microfluidic channel was designed into a spiral shape, which significantly enhanced the efficiency of 
interstitial exchange within the islets;  iii | A U-shape cups tissue array in a microfluidic chip for real-time 
imaging of multiple islets 162. The tissue array was shown to capture pancreatic islets without clogging in the 
perfusion channel; iv | A 3D perfusion well in a microfluidic chip for multi-parametric measurements of 




By incorporating the different analytical tools into the MPS, the multi-parametric devices have 
been invented and work as multiplexed sensors in studying islet. To date, optical sensing 
technique and capillary electrophoresis immunoassay (CEI), are two major protocols that are 
applied on MPS for islet study 159,165-174, both of which permit a number of key factors (Table 
1.5) influencing the insulin secretion to be monitored in parallel. The major advantages of using 
microfluidic devices include: (i) the high-degree automation for multiplexing measurement 
against independent fluorescent imaging and protein analysis 163, leading to the significantly 
increased working efficiency and reproducibility 150,175,176; (ii) the high reproduction of the 
microenvironment of the cell interplay in vivo by dynamically controlling in vitro culture, 
which is promising for studies on intercellular communication and interaction between 
different tissues. For example, the MPS platform has been utilised to investigate the effect of 
the interaction between gut and islet on GSIS 164; (iii) the high compatibility of MPS with a 
number of emerging techniques, such as the patch clamp, amperometry and surface plasmon 
resonance 151, displaying the potential for being modified into a multiplexed sensor. 
 
Table 1.5 | The versatile MPS-based devices for islet study 
Targets Analytical Tools Subject Aim / Finding 
NAD(P)H Auto-fluorescence  MIN6 cells; Established a multiparametric MPS for 
investigating the metabolic activity 
underlying the regulation of insulin 
secretion via paralleled measurement of 
oxygen consumption, NAD(P)H, [Ca2+]c and 
insulin release 163. 






Insulin  ELISA  
[Ca2+]c Fura-2/Fura-PE-3 Single murine Constructed a dual detection system that can 
simultaneously measure the intracellular 
factor and extracellular release 160.  
Insulin CEI islet 
[Ca2+]c Fura-2 Mouse/human  Fabricated a pumpless MPS, providing a 
simplified microfluidic device for islet study 
177. 
MMP Rh123 islet 
Insulin ELISA  
[Ca2+]c Fura-2 Mouse/human Largely improved the spatiotemporal 
resolution, enabling the monitor of the 
viability and activity of a large cell 
population at the single islet level 162. 
MMP Rh123 islet 
Tissue 
Viability 
CMFDA/PI   





Measured secretion rate of 9 amino acid 
secreted from pancreatic islets in real-time 
178. 
 
Although MPS is currently promising for the reconstruction of in vivo model by recapitulating 
the complex feature of a biological system, further improvements are required before the MPS 
can be promoted as a common method. Firstly, the microfluidic devices so far require 
sophisticated skills and facilities from design to on-bench application. Simplification, 
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particularly the experiment set up, is necessary for those devices to achieve widespread use, 
ideally a daily benchtop analyser. Secondly, the MPS devices are expected to enable the 
simultaneous tracking of a variety of biomarkers, i.e. ions, hormones and neurotransmitters in 
the interstitial space. With the capability of multiplexed sensing, the microfluidic devices will 
significantly accelerate the analysis procedure and provide insightful results for complex 
biological events.   
 
1.5 Research objectives 
The aim of the thesis is to develop an advanced microfluidic sensing platform that can be used 
for simultaneously monitoring the dynamic changes of Ca2+ in the extracellular environment 
and the secretion of insulin (and perhaps other metabolic hormones) from the islets or 
endocrine pancreas, which involves: 
 
1. Establishment of a fluorescence-based method capable of quantitatively and selectively 
measuring dynamic sub-millimolar [Ca2+] fluctuations against a high [Ca
2+] 
background (around 1mM). 
 
2. To design, fabricate and characterise a microfluidic device capable of immobilizing 
pancreatic islet while providing dynamically controllable nutrient and stimulation to 
regenerate the in vivo secretion environment. 
 
3. Demonstration of the capacity of the sensor for simultaneous measurement of the 










Chapter 2  
 
Evaluation of synthetic fluorescent Ca2+ indicator for 
[Ca2+]ex sensing   
 
The work of this chapter has systematically evaluated the feasibility of utilising Calcein and 
Rhod-5N as fluorescent sensors for monitoring [Ca2+]ex in the biological system. This 
evaluation covers the critical optical properties of the indicators, fluorometric responses in the 
presence of Ca2+, and their selectivity profiles. By comparing the performance of these two 




2.1.1 Fluorescent Ca2+ indicator with low binding affinity 
As aforementioned, the [Ca2+]ex is generally two orders magnitude higher than the [Ca
2+]c. This 
fact prevents the direct transition of fluorescent Ca2+ indicators for intracellular applications to 
extracellular events, as the Ca2+ indicators for the intracellular environment are easily saturated 
in the extracellular fluid. The saturation means that the binding sites of the intracellular 
indicator molecules are fully occupied by Ca2+ even with a concentration lower than basal 
extracellular Ca2+ level. These saturated indicators are inert to the changes of [Ca2+] and unable 
to reflect the dynamic changes of [Ca2+] during physiological events. Therefore, fluorescent 
Ca2+ indicator with low binding affinity, referring to the indicators that are turned on and 
display distinctive fluorescent signal in the presence of a high concentration of Ca2+, is a 
prerequisite for [Ca2+]ex study. Currently, two types of fluorescent indicators with low binding 
affinity and thus high dissociation constant (Kd, 0.1~10 Kd is the general sensing range of the 
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indicator) have been developed: one is based on the well-known 1, 2- bis(o-
aminophenoxy)ethane-N, N, N’, N’-tetraacetic acid (BAPTA) 179,180, and the other based on 
tetraphenylethene (TPE)-appended polyacrylic acid (PAA) 181. Both high-Kd indicators are 
capable of sensing [Ca2+] around 1mM and are competent for Ca2+ in the highly ionic 
environment of extracellular fluid.  
The production of the low-affinity indicators is principally based on the strategy that alters the 
ratio of Ca2+ binding domain (i.e. the carboxylic group) to the fluorophore molecule. Due to 
the excellent ion selectivity of BAPTA-based fluorescent indicator, many efforts are made to 
modify these fluorescent indicators to tune up the range of sensing capability to [Ca2+]. For 
BAPTA-based fluorescent indicators (unmodified), they are typically composed of four 
carboxylic groups as the Ca2+ binding units 79. By truncating the carboxylic groups into half, 
the Ca2+-binding strength of the indicators is reduced 182,183. He, H. et al synthesised the 
indicator based on anisine-N, N-diacetic acid, which consists of fluorophore and half of the 
binding units of BAPTA (Fig. 2.1a, left). By weakening the binding strength, their modified 
indicator exhibited a 34%/mM fluorescence change in the Ca2+ range of 0.3-2.2mM (Fig. 2.1a, 
right). This modified BAPTA-based indicator showed excellence for [Ca2+]ex
 measurement 
with outstanding selectivity to Ca2+ over Mg2+, but also performed highly stable in aqueous 
solution179. Although Mg2+ is often regarded as one of the major interference ions for [Ca2+]ex
 
sensing, the general use of this indicator in complex physiological conditions is pending 
without the evaluation on the selectivity of the indicator to Ca2+ versus other physiological 
metal ions, e.g., Na+, K+ and Fe
2+ at physiological concentrations.  
In another study, Kevin and his colleagues developed the indicator utilizing truncated BAPTA 
as the Ca2+ recognition unit, and the fluorophore, boron-dipyrromethene (BODYPY) (Fig. 2.1b, 
left) 180. With the weakened Ca2+ recognition site, the indicator displayed a Kd around 0.92mM 
to Ca2+ (Fig. 2.1b, right) and on average 9 times higher selectivity to Ca2+ over other metal ions 
in physiological condition. The results gained from cell experiment demonstrated this cell-






Figure 2.1 | Emerging low-affinity Ca2+ indicators for measuring the high concentration of Ca2+. a | A 
low-affinity Ca2+ indicator was designed based on truncated BAPTA 179. The indicator consisted of a 
BAPTA-based Ca2+ recognition unit and a fluorophore (left). The indicator exhibited significant fluorescence 
changes in presence of Ca2+ from 0 to 5mM (right);  b | A BODYPY-based low-affinity Ca2+ indicator was 
synthesised for Ca2+ quantification in blood sample 180. The fluorescent principle mediated by PET (left). 
The fluorescence changes in response to increasing Ca2+ concentrations (right); c | A gel form Ca2+ sensor 
based on PAA-TPE 181.  Fluorescent principle of the AIE-induced fluorescence within g-PAA-TPE in sensing 
Ca2+ (top); the fluorescence changes in response to the alteration in [Ca2+] presented by an artificial flowing 
system (bottom).  
 
However, it is found that the application of these modified BAPTA-based Ca2+ indicators with 
low-affinity is still limited. This is likely because the boundary-free extracellular environment 
poses challenges to the applications of these small molecule-based indicators. As the molecule-
based indicators tend to aggregate or diffuse away from the place of interest, the unstable 
concentration of the indicators would significantly interfere with the accuracy of the long-term 
recording. To overcome this issue, Ishiwari, F. et al. synthesised a polymer gel-based sensor, 
which was composed of Ca2+ binding backbone polyacrylic acid (PAA) and luminogen 
tetraphenylethene (TPE) 181. When the functional carboxylic acid bound with Ca2+, the 
chemically-crosslinked PAA experienced a single-chain aggregation. As the aggregation-
induced emission (AIE) luminogenic TPE was attached to the PAA backbone, the 
conformational changes from isolated form to aggregation state was translated into fluorescent 
signals, which was dependent on the [Ca2+] (Fig. 2.1c, top) 184.  Similar to the BAPTA 
indicators, the ratio of the fluorophore and binding domain in PAA-TPE could be tuned by 
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adjusting the ratio between the backbone PAA and the pendants TPE (containing the Ca2+ 
binding carboxylic groups). The consequent sensors displayed varying binding efficiency 185, 
resulting in a serial Kd ranging from 0.43 – 13mM, which was a comparable range to the 
fluctuation of [Ca2+]ex. Moreover, this indicator showed at least 4 times higher selectivity to 
Ca2+ than that to other metal ions at physiological concentrations. In order to test the temporal 
resolution, the indicator had been integrated into a micro-perfusing system, where the gel-form 
indicators showed fluorescent signal changes in response to pseudo extracellular fluids with 
oscillating concentrations of Ca2+ (Fig. 2.1c, bottom). However, the maximum fluorescence 
intensity induced by Ca2+ was approximated only 110% of the background fluorescence in the 
absence of Ca2+. The limited signal to background ratio prevents the application of the indicator 
on recording minor fluctuations of [Ca2+].  
 
2.1.2 Calcein and Rhod-5N 
Although much attention has been paid to the development of novel fluorescent indicators for 
sensing [Ca2+]ex, the evaluation of commercially available indicators for monitoring [Ca
2+]ex is 
largely neglected. With a comprehensive literature review, two fluorescent Ca2+ indicators, 
Calcein and Rhod-5N, are identified to be potentially competent candidates. 
Calcein is a versatile fluorescent indicator in terms of its fluorometric properties and 
applications. As shown in the top panel of Fig. 2.2a, Calcein consists of one fluorescein and 
two methyleneiminodiacetic acid groups attached to the xanthene portion of the fluorescein. 
Theses methyleneiminodiacetic groups serve as ion chelators, which interact with ions and 
significantly affect the fluorescence of the molecule (Fig. 2.2a, top) 79. First introduced in 1956, 
Calcein displayed a remarkable yellow-green fluorescence in the presence of metal ions, most 
notably Ca2+ 186 (Fig. 2.2a, middle). These useful fluorometric properties were soon utilised to 
develop quantitative methods for analysing serum Ca2+ concentrations in an alkaline 
environment (Fig. 2.2a, bottom)187-189. Owing to the pH- and concentration-dependent 
fluorometric properties of fluorescein, the fluorescence of Calcein is directly influenced by the 
pH of the working environment and the concentration of applied Calcein 190. As a result, 
dependent on the working environment (alkaline or neutral solutions), Calcein can exhibit both 
fluorescence enhancement and quenching in response to the ions of interest. For example, the 
enhanced optical signal was observed in the presence of Cd2+ via the formation of Cd2+-Calcein 
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fluorescent complex at high pH 191, while the fluorescence of Calcein was quenched by Fe2+, 
Cu2+, UO2
2+, rare earth ions under about neutral pH conditions 192-196.  
Rhod-5N is another promising fluorescent indicator for measuring [Ca2+]ex. As far as the best 
of our knowledge, Rhod-5N provides the lowest binding affinity with Ca2+ (Kd = 320μM) 
among the commercially available fluorescence-based Ca2+ indicator. Rhod-5N, a derivative 
of rhodamine-based indicator, is featured by high fluorescent efficiency with emission peak 
around 580nm (Fig. 2.2b, top and middle). In the absence of Ca2+, Rhod-5N is essentially non-
fluorescent; in contrast, the presence of Ca2+ switches on the indicator with two orders of 
magnitude fluorescence enhancement. In the previous study, 3mM Rhod-5N was filled in a 
micro-droplet (a concentric glass shell) in junction with a micro-pipette to form a probe. The 
microprobe was placed in the interstitial fluid of neural cells around which the [Ca2+]ex 
dynamics was recorded by the micro-pipette probe. As shown in the bottom panel of Fig. 2.2b, 
the micro-probe displayed a linear response to 0 – 2mM of Ca2+.197 Besides the extracellular 
Ca2+, Rhod-5N was used for monitoring the dynamic [Ca2+] changes in the intracellular 
compartments with a high [Ca2+], e.g., mitochondria 198,199. Compared with Calcein that is 
sensitive to the pH of the environment or the indicator concentration, Rhod-5N is relatively 
independent of these factors, but it is noteworthy that the ionic strength could influence the 





Figure 2.2 | Introduction to Calcein and Rhod-5N. a | The molecular structure of Calcein in AM ester 
form (top); the fluorescent excitation (blue) and emission (red) spectra of Calcein (middle); The application 
of Calcein in quantifying the Ca2+ concentration in serum (bottom) 187; b | The molecular structure of Rhod-
5N in AM ester form (top); the excitation (blue) and emission (red) spectra of Rhod-5N (middle); the 
application of Rhod-5N in measuring [Ca2+]ex in proximity to a neural cell (bottom) 201.  
 
2.2 Sample preparations, data acquisitions and analysis methods 
2.2.1 Apparatus and reagents  
The spectroscopic profiles of both Calcein and Rhod-5N were measured by Synergy H4 Hybrid 
Multi-Mode Microplate Reader (BioTek, USA) in 96-well assay plate (black plate, clear 
bottom, Corning, USA) at room temperature. The scanning speed was set as 2nm with the 
bandpass at 9nm. The sample volume for all samples was fixed at 100μL in each well for 
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quantitative comparison. For higher accuracy in a quantitative study, all spectra here were 
recorded with duplicate measurements at room temperature.  
The pH of all samples was pre-adjusted accordingly by a pH metre (827 pH lab Metrohm, 
NSW, Australia). The pH metre was calibrated with buffer solutions pH 4, 7 and 9 (Metrohm, 
NSW, Australia) before the first measurement in the day.  
All glassware used throughout the experiment was cleaned by washing with detergent, 
sonicating for 15 minutes, followed by rinsing with distilled water. Then the glassware was 
flushed three times with acetone (Chem Supply, Australia) and blow dried. After that, the 
glassware was rinsed with deionised (DI) water (Milli-Q, Australia) before drying.  
Ca2+, Mg2+, K+, and Na+ ions were provided in the form of chlorate salts (Chem-Supply, 
Adelaide, Australia). Other metal ions, such as Fe2+, Cu2+, Zn2+, and Al3+ were provided in the 
form of perchlorate salts (Sigma-Aldrich, St. Louis, USA). The reagents (shown in Table 2.1) 
for the preparation of phosphate-buffered saline (PBS) were purchased from Chem-Supply 
(Adelaide, Australia). All the salts were in analytical grade and used without further 
purification.  
The fluorescent indicator Calcein (>93%) was purchased from Sigma-Aldrich (Sydney, NSW, 
Australia) and Rhod-5N (tripotassium salt, cell impermeant) was purchased from Life 
Technologies (Mulgrave, VIC, Australia). Both indicators were supplied in crystalline solid 
and directly dissolved in a freshly prepared solvent before use. 
 
2.2.2 Fluorometric characterisation of Calcein as a function of Calcein concentration (pH 
7.4) 
As fluorometric properties of Calcein are significantly affected by the Calcein concentration 
and pH of the working environment, its excitation and emission spectra as a function of Calcein 
concentration were first studied at pH 7.4. Taking into account the slight solubility of Calcein 
in water and the following biological demonstrations, PBS was used as the solvent to dissolve 
Calcein in this experiment.   
Considering the strong acidifying effect of Calcein, a 500ml pH 12 PBS buffer was prepared 
and used to directly dissolve Calcein as the stock solution, and a 500ml pH 7.4 PBS buffer was 
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prepared to dilute Calcein into serial concentrations. Both of the PBS buffers were freshly 
prepared prior to the preparation of Calcein solution. The compositions of PBS buffer (shown 
in Table 2.1) were dissolved in DI water and the pH was adjusted to 12 and 7.4 with 2 M NaOH 
and 3% HCl respectively.   
 







NaCl 137 8.0 4 
KCl 2.7 0.2 0.1 
Na2HPO4 10 1.42 0.71 
KH2PO4 1.8 0.24 0.12 
 
A 20mM stock solution of Calcein was prepared by dissolving 622.5mg Calcein (MW = 622.53) 
in pH 12 PBS buffer. Before use, the stock solution was pre-adjusted to pH 7.4 and 
subsequently diluted into serial concentrations of Calcein from 0.5μM to 18mM by pH 7.4 PBS 
buffer.  
Regarding the optical measurements, excitation spectra were obtained from 250 to 550nm with 
the emission fixed at 580nm. The gain rate was set as 50 % with a read height of 8mm. Emission 
spectra were obtained between 490 and 700nm with the excitation fixed at 470nm. The gain 
rate was set as 50 % with a read height of 8mm. 
 
2.2.3 Fluorometric characterisation of Calcein (3mM) as a function of pH 
In order to investigate the fluorometric properties of Calcein in various pH environments, the 
fluorescent excitation and emission of Calcein were measured in a range of pH between 3 and 
12. A 3mM Calcein solution was prepared by dissolving 62.25 mg Calcein in 50mL pH 7.4 
PBS. The pH of the solution was subsequently adjusted into 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 with 
2M NaOH and 3% HCl. Excitation and emission spectra were obtained with the identical 




2.2.4 Fluorescent characterisation of Calcein in response to Ca2+ at pH of 12 and 7.4 
As abovementioned in 2.1.2, previous studies suggested that Calcein showed significant 
fluorescent signals in response to Ca2+ in serum samples in an alkaline environment (pH 12). 
However, the final concentrations of both Calcein and Ca2+ were around 10μM and the serum 
samples were diluted. As the previous reports provided hints on the pH condition, it is 
worthwhile to investigate the feasibility of using Calcein to quantify high [Ca2+] without 
dilution at pH 12. Therefore, the Ca2+-induced fluorometric response of Calcein was 
systematically evaluated in the presence of 0-2mM Ca2+ at pH 12 in this work to examine the 
feasibility of utilising Calcein for [Ca2+]ex detection. In addition, the sensing environment was 
adjusted to pH 7.4 to explore whether Calcein is capable to detect [Ca2+]ex at a biologically 
relevant pH. 
A stock solution of 20mM Calcein was prepared by dissolving 622.5mg Calcein in 50mL pH 
12 PBS and the pH of the stock solution was adjusted to 12. The Calcein stock solution was 
subsequently diluted into 0.1, 0.2, 1, 2, 4 and 6mM with pH 12 PBS buffer. A stock solution 
of 200mM Ca2+ was prepared by dissolving 588.08mg CaCl2•2H2O (MW=147.02, Chem-
Supply, Adelaide) into 20ml DI water. The Ca2+ stock solution was subsequently diluted with 
DI water into 0-4mM with an interval of 0.5mM as well as 5, 6, 10, 14, 20mM, respectively. 
Sample for measurement was prepared by adding 50μL Calcein solution and 50μL Ca2+ 
solution into one well with proper mixing. Emission spectra were obtained between 490 and 
700nm with the excitation fixed at 470nm. The gain rate set as 50 % with a read height of 8mm. 
Additionally, to investigate the applicability of Calcein in a physiological environment, the 
Calcein emission spectra were measured in the presence of Ca2+ at pH 7.4. The 20mM Calcein 
stock solution was diluted into 0.5, 1, 1.5, 2mM with pH 7.4 PBS buffer, followed by adjusting 
the final pH to 7.4. The emission spectra were obtained with the identical setting as described 
above (for pH 12 case). 
The fluorescent profiles of Calcein in varying conditions were compared to determine the 
optimal concentration and working environment for Calcein, where Calcein displayed the most 
significant fluorescence changes in response to the increasing Ca2+ concentration. Similarly, 
the optimal concentrations and working environment for Rhod-5N were identified based on the 
results from section 2.2.5. The optimised conditions for these two indicators were used in 
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section 2.2.6 and 2.2.7 for further characterisations on the selectivity and fluorescent response 
to Ca2+ in biological samples. 
 
2.2.5 Fluorescent characterisation of Rhod-5N in response to Ca2+ at pH 7.4 
To identify the optimal concentration and solvent for Rhod-5N as an [Ca2+]ex indicator, the 
emission spectra of serial concentrations of Rhod-5N dissolved in DI water and pH 7.4 PBS 
buffer were measured in the presence of Ca2+, respectively.  
For Rhod-5N in DI water, a stock solution of 0.1mM Rhod-5N was prepared by dissolving 
500μg Rhod-5N into 5.56mL DI water. The 0.1mM Rhod-5N stock solution was subsequently 
diluted into 5μM and 50μM with DI water. The Ca2+ solutions were prepared as described in 
2.2.4. Sample for measurement was prepared by adding 50μL Rhod-5N solution and 50μL Ca2+ 
solution into one well with proper mixing. Emission spectra were obtained between 555 and 
700nm with the excitation fixed at 535nm. The gain rate set as 50 % with a read height of 8mm. 
For Rhod-5N in PBS solution, a stock solution of 1mM Rhod-5N was prepared by dissolving 
500μg Rhod-5N into 0.556mL pH7.4 PBS buffer. The 1mM Rhod-5N stock solution was 
further diluted into 5, 10, 20, 50, 100, 250μM with pH 7.4 PBS. The sample preparation and 
emission spectra measurement were performed as above mentioned. 
 
2.2.6 Fluorescent characterisations of Calcein and Rhod-5N in response to other metal 
ions  
To study the selectivity of Calcein and Rhod-5N towards Ca2+, the emission spectra of Calcein 
and Rhod-5N were recorded in response to various metal ions in the extracellular environment 
in the absence and presence of Ca2+. 
As shown in Table 2.2, the stock solutions of various metal ions were prepared by dissolving 
the corresponding salts in DI water. The stock solutions were further diluted into the sample 
concentrations with DI water. It is worth noting that the sample concentrations were 
intentionally prepared as 2 times of the ion concentrations in the extracellular environment. As 
the sample is 1:1 mixed with the indicator solution in the 96-well plate for fluorescence 
measurement, the final concentrations of ions would be the physiological concentrations in the 
36 
 
extracellular fluid. The fluorescence measurements were performed as described in section 
2.2.4 for Calcein and 2.2.2 for Rhod-5N.   
 
Table 2.2 | The preparation of metal ion stock solutions for investigating selectivities of Calcein and 









CaCl2 ·2H2O 147.02 10 2  
AlK(SO4)2 · 12H2O 474.21 10 0.1  
KCl 74.55 100 10   
MgCl2·6H2O 203.3 10 2  
NaCl 58.44 500 300  
Cl2FeO8 254.75 10 0.1  
Zn(ClO4)2·6H2O 372.38 10 0.1  
MnSO4 · 4H2O 273.06 10 0.1  
Cu(ClO4)2 · 6H2O 370.54 10 0.1  
 
2.2.7 Fluorescent characterisations of Calcein and Rhod-5N in the presence of Ca2+ in cell 
culture medium 
To confirm the sensing performance of Calcein and Rhod-5N in a physiologically relevant 
environment, the fluorescence of Calcein and Rhod-5N were measured in the presence of Ca2+ 
dissolved in cell culture medium at 37°C to characterise the sensing performance of the two 
indicators.  
To prepare the Ca2+ solution in the cell culture medium, the 200mM Ca2+ stock solution was 
diluted into 0-4mM with Ca2+-free Dulbecco’s Modified Eagle Medium (DMEM) (Life 
Technologies, Australia). DMEM is a basal medium used in cellular biology for supporting the 
growth of a variety of mammalian cells and it contains various ions and nutrients such as 
glucose, amino acid and vitamins. The fluorescence measurements were performed as 
described in section 2.2.4 for Calcein and 2.2.2 for Rhod-5N   
 
2.2.8 Data analysis 
Excitation and emission spectra of indicators were averaged in duplicate measurements. The 
peak value of fluorescence intensities of the emission spectra was used for fluorescence 
analysis. Specifically, fluorescence intensities at 530nm and 580nm were determined for 
Calcein and Rhod-5N respectively. 
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The fluorescent characterisation indicated that the target concentrations of Ca2+ (0-2mM) 
induced the fluorescence quenching of Calcein (section 2.3.3) and fluorescence enhancement 
of Rhod-5N (2.3.4), respectively. To quantitatively characterise the fluorescent responses of 
the indicators, the Ca2+-induced fluorescence quenching of Calcein was described by the Stern-
Volmer relationship, while the Kd of Rhod-5N-Ca
2+ interaction was computed. The Stern-
Volmer relationship formulates the ratio of background fluorescence in the absence of Ca2+ to 
the fluorescence in response to Ca2+ (F0/F) and the concentration of the quencher ([Qu], which 
is Ca2+ in this case). For Rhod-5N, Kd was computed with [Ca
2+], fluorescence in the presence 
of Ca2+ (F) and the Ca
2+-induced maximum fluorescence (Fmax). 
 
2.2.8.1 Stern-Volmer relationship for Calcein 
The fluorescence quenching of a fluorophore as a function of [Qu] can be described by the 
Stern-Volmer equation 202: 
𝐹0
𝐹
= 1 + 𝐾𝑆𝑉[𝑄𝑢]     (𝐸𝑞. 2.1) 
where F0  and F are the fluorescence intensity of a fluorophore in the absence and presence of 
the quencher, respectively, and KSV is the Stern-Volmer quenching constant 
202. By plotting the 
ratio of F0 and F of Calcein as a function of [Ca2+], the quenching constant KSV could be 
determined from the slope of the linear fitting of the graph. It is useful to note that the KSV 
-1 
indicates the quencher concentration at which 50% of the fluorescence is quenched (F0/F=2). 
 
2.2.8.2 Ionic calibration and dissociation constant of Rhod-5N - Ca2+ binding 
The dynamic interaction between the ligand Ca2+ (Ca2+), receptor Rhod-5N (N) and their 
complexed (CaN) can be expressed as: 
𝐶𝑎𝑁 ⟺ 𝐶𝑎2+ + 𝑁     (𝐸𝑞. 2.2) 
According to the mass law, the equilibrium concentrations of the Ca2+, [Ca2+], of the Rhod-5N, 




     (𝐸𝑞. 2.3) 
38 
 
In fluorescent sensing, the fluorescent signal F is proportional to the number n of bound Rhod-
5N molecules (same as the bound Ca2+). The value of F can be expressed as: 
𝐹 = 𝜑𝑛     (𝐸𝑞. 2.4) 
where 𝜑 is the proportionality factor. At saturation, F=Fmax. Therefore, the concentration of 
Ca2+ can be further expressed as: 
[𝐶𝑎2+] =  𝐾𝑑
𝐹
𝐹𝑚𝑎𝑥 − 𝐹
     (𝐸𝑞. 2.5) 
Generally, the ion concentration in fluorescent sensing refers to the ionised concentration 
([Ca2+]i in this case) in the solution. However, due to the shielding effect posed by the ionic 
environment, the available ion for binding, called effective concentration ([Ca2+]e), is smaller 
than the ionised concentration. The effective concentrations of Ca2+ can be calibrated with the 
activity coefficient in order to precisely characterise the dissociation equilibrium between 
Rhod-5N and Ca2+. The relationship between [Ca2+]e and [Ca
2+]i can be presented as: 
[𝐶𝑎2+]𝑒 = 𝛾𝑖 × [𝐶𝑎
2+]𝑖     (𝐸𝑞. 2.6) 
where γi is the activity coefficient, which describes the relationship between the effective 
concentration and the ionised concentration of an ion species under certain conditions. In an 
ionic solution, γi of a specific ion is determined by the ionic strength of the solution and the 
temperature of the environment. γi can be calculated the Davis formula 203. 




− 0.3 × 𝐼)    (𝐸𝑞. 2.7) 
where a is the coefficient constant, zi is the valence of the ion and I is the ionic strength of the 
solution. The coefficient constant can be determined as: 
𝑎 = 1.82 × 106  × (𝜀𝑇)−3/2     (𝐸𝑞. 2.8) 
where the temperature T is in Kelvin and the dielectric constant ɛ of water at 37°C is 74.123 
204. Therefore, a is calculated to be 0.523. The ionic strength of the solution is expressed as 205:  
𝐼 =  
1
2
 ∑ 𝑐𝑖 𝑧𝑖
2     (𝐸𝑞. 2.9) 
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where ci is the ionised concentration of an ion. The ionic strength of the sample was determined 
to be 167.217mM based on the ionic species in the solvent for Ca2+ (cell culture medium) and 
for Rhod-5N (PBS). The final concentrations of the ionic components were listed in Table 2.3 
based on the gradients of cell culture medium and PBS.  
 
Table 2.3 | The concentrations of the ionic components 









With the calculated a and ci, γi was further calculated to be 0.3145 based on Eq. 2.7. The 
effective concentration of Ca2+ in the sample was expressed as: 
[𝐶𝑎2+]𝑒 = 0.3145 × [𝐶𝑎
2+]𝑖     (𝐸𝑞. 2.10) 
Therefore, Eq. 2.5 was further written as 
𝐹 = 𝐹𝑚𝑎𝑥 ×
[𝐶𝑎2+]𝑒
𝐾𝑑 + [𝐶𝑎2+]𝑒 
     (𝐸𝑞. 2.11) 
The Eq. 2.11 correlates the measured fluorescence intensity F against the effective 
concentration of Ca2+. The plot according to Eq. 2.11 was analysed by ‘Hill’ function under 
the Growth/Sigmoidal category. The model was formulated as: 
𝑦 = 𝑉𝑚𝑎𝑥 ×
𝑥𝑛
𝑘𝑛  +  𝑥𝑛
     (𝐸𝑞. 2.12) 
where y, Vmax, x and k correspond to F, Fmax, [Ca
2+]e and Kd, respectively. n is equal to 1 for a 
monomer binding reaction without cooperativity to another binding site. If n is greater than 1, 
it indicates that there are multiple binding sites with positive cooperativity 206 
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2.3 Results  
2.3.1 Excitation and emission spectra of Calcein as a function of Calcein concentration at 
pH 7.4  
The fluorometric spectra of Calcein have been reported to be significantly affected by the 
concentration of Calcein. Therefore, the excitation and emission spectra of Calcein were firstly 
examined as a function of Calcein concentration from 0.5μM to 20mM.  
The excitation spectra of different concentrations of Calcein at the pH of 7.4 are shown in Fig. 
2.3. It is clear that the overall excitation intensity enhanced as the concentration of Calcein 
increased from 0.5μM to 2mM. The excitation intensity began to drop after the concentration 
of Calcein was higher than 4mM (Fig. 2.3a). At low concentrations of Calcein (<5μM), the 
excitation spectra consisted of a major band peaking at around 495nm with a distinct shoulder 
on the left of the peak at around 480nm. A few minor bands were also observed at around 
320nm (Fig. 2.3b).  
 
 
Figure 2.3 | The excitation spectra of Calcein in PBS as a function of Calcein concentration at pH 7.4. 
(λex = 250-550nm, λem = 580nm) a | 3D plot of Calcein excitation spectra as a function of Calcein 
concentration; b | 2D plot of the excitation spectra of serial concentrations of Calcein. 
 
The emission spectra of Calcein at pH 7.4 are shown in Fig. 2.4a, displaying a consistent overall 
trend of the fluorescence intensity. The spectra consisted of a single major band and a shoulder 
on the right of the peak at around 530nm. To further study the effect of Calcein concentration 
on its fluorescence, the peak fluorescence of Calcein at 530nm was plotted against the 
concentration of Calcein as shown in Fig. 2.4b. For the serial concentrations of Calcein at the 
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pH of 7.4, the fluorescence intensity of the Calcein at peak wavelength increased as the 
concentration increased from 0.5μM to 4mM, followed by decreasing fluorescence when the 
concentration increased over 4mM to 20Mm (Fig. 2.4b). Therefore, 3mM was selected for 
further analysis on the effect of pH on the fluorescence of Calcein to take advantage of the high 
fluorescence.   
 
 
Figure 2.4 | The emission spectra of Calcein in PBS as a function of Calcein concentration at pH 7.4. 
a | 3D plot of Calcein emission spectra as a function of Calcein concentrations(λex = 470nm, λem = 490-
700nm); b | Fluorescence intensity of Calcein as a function of Calcein concentration (pH7.4, λex = 470nm, 
λem = 530nm). 
 
2.3.2 Excitation and emission spectra of Calcein (3mM) as a function of pH  
In order to understand the effect of pH on the fluorometric properties of Calcein, the excitation 
and emission spectra of 3mM Calcein were measured from 250-550nm and 490-700nm, 
respectively, for a range of pH from 3 to 12.  
The excitation spectra of 3 mM Calcein in PBS buffer are shown in Fig. 2.5 as a function of 
pH. The overall excitation intensity slightly increased as the pH increases from 3 to 4. The 
intensities remained constant between pH 4 and 10 with a redshift from 504 to 524nm. The 
excitation underwent a sharp drop as the pH increased from 10 to 12 and the intensity at 12 
was around 6% of the intensity at pH 7 (Fig. 2.5a). It is clear in the 2D plot that 3mM of Calcein 
displayed a broad excitation from 300nm to 520nm and the increasing pH induced the blue 




Figure 2.5 | The excitation spectra of 3mM Calcein in PBS as a function of pH. (λex = 250-550nm, λem 
= 580nm) a | 3D plot of Calcein excitation spectra as a function of pH (3-12); b | 2D plot of the excitation 
spectra of Calcein at pH 3-8. 
 
The emission spectra of 3mM Calcein were plotted as a function of pH as shown in Fig. 2.6. 
The overall trend of fluorescence intensity was slightly different from the excitation spectra. 
The emitted fluorescence of Calcein enhanced as the pH increased from 3 to7. From pH 8 to 
10, the emission strength slightly decreased, followed by tremendous decreases in the 
fluorescence from at pH 11 and 12 (Fig. 2.6a). The 2D plot of the spectra shows that the peak 
emission of Calcein experienced blue shift with the increasing pH. Although the 
autofluorescence of Calcein was significantly lower at pH 12, the addition of Ca2+ might induce 
substantial change to the fluorescence at this pH condition as discussed in section 2.1.2 and 
2.2.4. Therefore, it is worthwhile to investigate the Ca2+-induced fluorescent response of 
Calcein at pH 12 in the following study.     
 
 
Figure 2.6 | The emission spectra of 3mM Calcein in PBS as a function of pH. (λex = 470nm, λem = 490-
700nm) a | 3D plot of Calcein emission spectra as a function of pH (3-12); b | 2D plot of the emission spectra 




2.3.3 Effect of indicator concentration, pH and temperature on the fluorescence of 
Calcein in response to Ca2+ 
To determine an optimal working condition for Calcein as an indicator for extracellular Ca2+, 
the fluorescence of serial concentrations of Calcein was measured in the presence of 0-2mM 
Ca2+ in an alkaline environment (pH 12) and physiologically relevant environment (pH 7.4), 
respectively.  
 
Figure 2.7 | The fluorescence intensity of serial concentrations of Calcein as a function of Ca2+ 
concentration at pH 12. (λex = 470nm, λem = 530nm) 
 
As discussed in the previous sections, the ratio between Calcein and Ca2+ was set approximately 
as 1:1. Considering the fluorescence quenching shown in the higher Calcein concentration 
might affect its sensitivity to Ca2+, the Ca2+-induced fluorometric response of Calcein was 
investigated with a wider range of Calcein (0.5-3mM) instead of only using 3mM to determine 
the optimal concentration of Calcein.  In this context, the emission profiles of 0.5, 1, 2 and 
3mM Calcein were examined with addition of increasing Ca2+ at pH 12. As shown in Fig. 2.7, 
Calcein at pH 12 exhibited ratio-dependent fluorescent signals in response to Ca2+. The 
fluorescence of Calcein (pH 12) decreased when the ratio of Ca2+ to Calcein increased from 0 
to 1 and the fluorescence increased when the ratio increased over 1. The fluorescence of Calcein 
reached a plateau when the ratio was between 2-2.5. Consequently, the lower concentration of 
Calcein (<2mM) showed reversed fluorescence signals from fluorescence quenching to 
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fluorescence enhancement in the presence of target Ca2+ (0-2mM), which justified the necessity 
to use higher concentrations of Calcein (>2mM). It is worth noting that 2mM Calcein displayed 
fluorescence quenching in response to 0-1.5mM Ca2+ and reached to a minimum fluorescence 
between 1.5-2mM Ca2+. Compared with 2mM of Calcein, the 3mM Calcein was more 
responsive to the target Ca2+ by showing continuous fluorescence quenching in response to 0-
2mM Ca2+. Therefore, 3mM Calcein was selected for the following experiments without 
further investigation on a higher Calcein concentration (>3mM), which might compromise the 
sensitivity of Calcein to Ca2+ due to enhanced self-quenching. 
The temperature has been shown to be an important factor for fluorescence quenching 207. As 
most preliminary fluorescence measurements were carried out in plate reader at room 
temperature, varying from the physiological conditions, i.e., 37°C in the body, the fluorescence 
of 3mM Calcein at room temperature (23°C) and 37°C in the presence of various [Ca2+] were 
compared at pH 12. As shown in Fig. 2.8, although the fluorescence intensities at 37°C were 
lower than that of at room temperature, the Ca2+-induced fluorescence quenching of Calcein 
was retained at both temperatures with almost identical quenching tendency as the increase of 
[Ca2+]. This comparison demonstrates that the evaluation results on Calcein at room 
temperature are meaningful. 
 
 
Figure 2.8 | The Ca2+-induced fluorescence quenching of 3mM Calcein at room temperature and 37°C 




As the Calcein is expected to be used in the biological environment, the fluorescence 
measurements of serial concentrations of Calcein were measured at pH 7.4 in the presence of 
various [Ca2+]. As shown in Fig. 2.9, the emission spectra of 5μM Calcein displayed 
undistinguishable change with the addition of Ca2+ in terms of the intensity and peak 
wavelength; for the spectra of 50μM, 0.5mM and 2mM Calcein, the slight intensity drop and 
minor blue shift of peak wavelength were observed with increasing [Ca2+]. For example, for 
2mM Calcein at pH 7.4, the largest fluorescence quenching caused by 2mM Ca2+ was less than 
8% on the basis of the background fluorescence in the absence of Ca2+ at around 526nm 
emission. These results confirm that the use of Ca2+-induced quenching of Calcein indicator is 
only feasible at the alkaline environment (pH 12) instead of the physiologically relevant 
environment (pH 7.4).  
 
 
Figure 2.9 | The emission spectra of 5μM, 50μM, 0.5mM and 2mM Calcein in the presence of Ca2+ at 
pH 7.4. (λex = 470nm, λem = 490-700nm) 
 
2.3.4 Stern-Volmer relationship between the fluorescence of Calcein and Ca2+ 
concentration  
As discussed in 2.2.8, the Stern-Volmer relationship provides insight into the quenching degree 




plotted for 3mM Calcein in the presence of 0-1.5mM Ca2+, where F0 and F were the 
fluorescence intensities in the absence and presence of Ca2+, respectively, dissolving in the cell 
culture medium at 37°C. As shown in Fig. 2.10, the Stern-Volmer quenching constant KSV, 
revealed by the slop of the linear fitting of the data points, was 0.413L/mM. The KSV indicated 
that the addition of 0.1mM Ca2+ induces a 3.94% fluorescence drop and 2.43mM Ca2+ would 
cause about 50% fluorescence quenching of Calcein, where F0/F was equal to 2. However, as 
the concentration of Ca2+ increased over 2mM, the fluorescence quenching of 3mM Calcein 
was reversed. Therefore, the Ca2+-induced fluorescence quenching of 3mM Calcein was 
expressed as Eq. 2.13 (applicable for [Ca2+] below 1.5mM). The maximum fluorescence 
quenching of 3mM Calcein was around 50% in this experiment. 
𝐹0
𝐹
= 1 + 0.413𝐿/𝑚𝑚𝑜𝑙 × [𝐶𝑎2+]     (𝐸𝑞. 2.13) 
 
 
Figure 2.10 | Ca2+ Stern-Volmer plot for Calcein as a function of Ca2+ concentration. (λex = 470nm, λem 
= 530nm) F0 and F were the fluorescence of Calcein in the absence and presence of Ca2+, respectively. 
 
2.3.5 Effect of solvent and indicator concentration on the fluorescence of Rhod-5N in 
response to Ca2+ 
As demonstrated in 2.1.2 section, in comparison to Calcein indicator, the fluorometric 
properties of Rhod-5N are stable at different pH 95. Moreover, Rhod-5N indicator is essentially 
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non-fluorescent in the absence of Ca2+. However, it was reported that the binding affinity of 
Rhod-5N to Ca2+ was significantly affected by the ionic strength of the solution. Thus, the 
effective Ca2+ sensing range could be influenced by the concentration of Rhod-5N and the ionic 
strength of the solvent used in the experiment. 
The emission spectra of Rhod-5N (2.5μM and 25μM Rhod-5N dissolved in DI water, 
respectively) were first measured in the presence of various [Ca2+]. As shown in Fig. 2.11a, the 
emission of Rhod-5N consisted of a major band peaking at around 580nm, accompanied by a 
shoulder around 610 to 640nm. With the addition of Ca2+ from 0.25mM to 2.5mM, the 
fluorescence intensities at peak wavelength were amplified up to over 100 times of the 
background fluorescence. Fig. 2.11b shows that the fluorescence intensity reached a plateau as 
the Ca2+ increased over 0.25mM for 2.5μM Rhod-5N and 1.25mM for 25μM Rhod-5N, 
suggesting the concentration of Rhod-5N positively correlated with the sensing range of Ca2+ 
in a certain indicator range. 
 
 
Figure 2.11 | The fluorescence of Rhod-5N in water in response to Ca2+. a | The emission spectra of 
25μM Rhod-5N in the presence of Ca2+. The inset shows the background fluorescence of Rhod-5N in the 
absence of Ca2+ (λex = 535nm, λem = 555-700nm); b | The Ca2+-induced fluorescence enhancement of 2.5μM 
and 25μM Rhod-5N in DI water (λex = 535nm, λem = 580nm). 
 
To understand the effect of ionic strength of the solution on the fluorescence of Rhod-5N, the 
spectra of 25μM Rhod-5N dissolved in pH 7.4 PBS buffer and DI water were compared. As 
shown in Fig. 2.12a, with the same indicator concentration, the Rhod-5N dissolved in PBS 
displayed a suppressed fluorescence increment, which suggested that the ionic strength of the 
solution negatively correlated with the Ca2+-Rhod-5N binding. Furthermore, to identify the 
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optimal concentration of Rhod-5N for [Ca2+] measurement, the emission spectra of a large 
range concentration of Rhod-5N were examined as a function of various [Ca2+]. As shown in 
Fig. 2.12b, for Rhod-5N around 50-100μM, there was the largest fluorescence enhancement 
for the target [Ca2+] (0-2mM). Therefore, 50μM Rhod-5N would be used as the final 
concentration in the sample.  
 
 
Figure 2.12 | The fluorescence of Rhod-5N in pH 7.4 PBS solution in the presence of Ca2+. (λex = 535nm, 
λem = 580nm) a | The fluorescence intensities of 25μM Rhod-5N dissolved in DI water and PBS, respectively, 
in the presence of various [Ca2+] (0-2mM). (Fmax was the maximum fluorescence intensity of Rhod-5N 
induced by Ca2+ (2mM) and F was the fluorescence intensity at a specific concentration of Ca2+); b | The 
fluorescence enhancement profiles for serial concentrations of Rhod-5N (from 2.5μM to 250μM) as a 
function of [Ca2+]. 
 
2.3.6 Selectivity of Calcein and Rhod-5N to Ca2+ over other metal ions in extracellular 
fluid  
Fig. 2.13a indicates that Ca2+ induces a major fluorescence quenching of Calcein under 
physiological conditions (first column labelled with Ca2+). The Ca2+-induced fluorescence 
quenching was more than 3 times higher than that by Mg2+, K+, Fe2+, Cu2+ and Al3+ ions. While 
the presence of Na+ or Zn2+ led to an increase in fluorescence intensity, the addition of 1mM 
Ca2+ led to the dominant fluorescence reductions.  
Fig. 2.13b shows that Rhod-5N exhibited a high selectivity to Ca2+. The 50μM Rhod-5N was 
non-fluorescent in the presence of Mg2+, Na+, K+, Fe2+ and Al3+ and the addition of 1mM Ca2+ 
induced the increase of the fluorescence intensity over 40 times. Nevertheless, the presence of 
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Cu2+ and Zn2+ induced a minor increase of the fluorescence, and more importantly, their 
existence significantly suppressed the Ca2+-induced fluorescence enhancement.  
 
 
Figure 2.13 | The fluorescence of Calcein and Rhod-5N in the presence of Ca2+ and other metal ions in 
extracellular fluid. a | The selectivity profile of 3mM Calcein in pH 12 PBS buffer (λex = 470nm, λem = 
530nm); b | The selectivity profile of 50μM Rhod-5N in pH 7.4 PBS buffer (λex = 535nm, λem = 580nm). F0 
and F were the fluorescence of the indicators in the absence and presence of Ca2+, respectively. The blue bar 
shows the fluorescence of the indicator in the presence of the single ion without Ca2+ and the red bar shows 
the fluorescence with the addition of 1mM Ca2+. The concentrations of each ion were set as their approximate 
concentrations in extracellular environment (Ca2+ 1mM, Mg2+ 1mM, Na+ 150mM, K+ 5mM, Fe2+ 50μM, 
Cu2+ 50μM, Zn2+ 50μM, Al3+ 50μM). 
 
To investigate whether the presence of Zn2+ and Cu2+ would affect the Ca2+ sensing capability 
of Rhod-5N, the full-ion solution containing all the above mentioned physiologically relevant 
metal ions were prepared with the corresponding concentrations. The concentrations of Ca2+ in 
the full-ion solution were adjusted to 0, 1, 2, 3, and 4mM, respectively. As the prepared Ca2+ 
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solution was 1:1 mixed with Rhod-5N solution (100μM), the final concentration of Rhod-5N 
was 50μM and the concentrations of Ca2+ were 0, 0.5, 1, 1.5 and 2mM, respectively, in the 
measurement. As shown in Fig. 2.14a, in the presence of physiologically relevant metal ions, 
50μM Rhod-5N showed the fluorescence increment in response to increasing concentration of 
Ca2+ from 0 to 2mM. Moreover, by dissolving Ca2+ in full-ion solution, the fluorescence change 
in response to Ca2+ variations turned out to display higher linearity, improving from 0.714 
(nonlinear, Ca2+ dissolved in DI water) to 0.978 (linear). Due to the presence of Cu2+ and Zn2+, 
the fluorescence enhancement factors of Rhod-5N in response to varying [Ca2+] was reduced, 
but Cu2+ and Zn2+ did not affect the excellent capability of Rhod-5N sensing Ca2+ (Fig. 2.14b).   
 
 
Figure 2.14 | The effect of metal ions the fluorescence enhancement of Rhod-5N in response to Ca2+. 
(λex = 535nm, λem = 580nm) a | The fluorescence of 50μM Rhod-5N in the presence of Ca2+ in full-ion 
solution; b | The linearity of the fluorescence intensity of 50μM Rhod-5N in response to Ca2+ DI water (red) 
and in full-ion solution (black). F0 and F were the fluorescence of the indicators in the absence and presence 
of Ca2+, respectively. 
 
2.3.7 Dissociation constant of Rhod-5N – Ca2+ binding 
As discussed in 2.2.8, the dissociation constant (Kd) of Rhod-5N to Ca
2+ can be determined by 
modelling the correlation between Ca2+-induced fluorescence intensity and the corresponding 
[Ca2+]. In this experiment, the fluorescence intensities of Rhod-5N were plotted against the 
corresponding effective [Ca2+] from 0.3145nM to 0.3145 M. As shown in Fig. 2.15, Hill plot 
equation was computed to be: 
𝑦 = 32068.213 ×
𝑥
0.000719 + 𝑥
     (𝐸𝑞. 2.14) 
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As k in Eq. 2.14 corresponds to the Kd in Eq. 2.11, the Kd of Rhod-5N and Ca
2+ interaction was 
determined to 0.719mM in cell culture medium at 37°C. Therefore, the optimal Ca2+ sensing 
range of 50μM Rhod-5N was 71.9μM to 7.19mM (correspond to 0.1~10 Kd, the range was 
visualised by the two vertical dashed lines in Fig. 2.15), during which Rhod-5N displayed a 
relatively linear fluorescence enhancement. 
 
 
Figure 2.15 | Ca2+ titration curve of Rhod-5N (50μM) measured from the emitted fluorescence intensity 
of Rhod-5N at 580nm. (λex = 535nm, λem = 580nm) The optimal Ca2+ sensing range was visualised by the 
two vertical dashed lines, corresponding to 0.1~10 Kd. 
 
2.4 Discussion 
In this chapter, two commercially available fluorescent Ca2+ indicators, Calcein and Rhod-5N, 
were systematically evaluated for sensing [Ca2+]ex. It was found that the 3mM Calcein indicator 
dissolved in pH 12 PBS buffer experienced a fluorescence quenching as [Ca2+] increases from 
0 to 2mM in both DI water and cell culture medium. The Stern-Volmer plot indicated a 3.97% 
fluorescence intensity drop was achieved by adding 0.1 mM Ca2+. Moreover, Calcein was 
highly selective to Ca2+ over other major and trace metal ions in the extracellular environment.  
On the contrary, Ca2+ induced significant fluorescence enhancement of 50μΜ Rhod-5N in pH 
7.4 PBS, where the intensity was amplified over 72 times in the presence of 2mM Ca2+. 
Although the Ca2+-induced fluorescence of Rhod-5N was significantly suppressed in the 
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presence of in vivo Cu2+ or Zn2+ ions (50 μM each), the fluorescent signals improved with the 
higher linearity in all-ions solution and remain sufficient for accurately quantifying [Ca2+] 
dynamics. In all-ions solution, Rhod-5N retained the ultra-sensitive response to the variations 
of [Ca2+], i.e., ΔF = 36.8 % per 0.1mM of Ca2+ (Table 2.4).  
 
Table 2.4 | Comparison of Calcein and Rhod-5N for sensing [Ca2+]ex 
Properties/Conditions Calcein Rhod-5N 
Concentration 3mM 50μM 
pH 12 7.4 
(Fmax - F0) / F0 -0.48 72 
ΔF (per 0.1mM Ca2+) 3.97% 36.8% 
Interference Na+ Cu2+, Zn2+ 
 
The quenching of Calcein, for the first time, was utilised to establish a quantitative method for 
measuring [Ca2+]ex. Calcein is known to undergo fluorescence quenching either in high Calcein 
concentration due to self-quenching or in the presence of certain metal ions at pH7.4, where 
Calcein displayed a strong background fluorescence 190.  It is worth noting that the mechanisms 
underlying these two quenching phenomena are different. While the self-quenching observed 
in a high concentration of Calcein was owing to the dynamic quenching via an increasing 
collision between Calcein molecules 208, the metal ion-induced fluorescence quenching was 
attributed to the static quenching by forming non-fluorescent complexes 193. As shown in Fig. 
2.8, at the same Ca2+ concentration, the fluorescence quenching of Calcein was enhanced at a 
higher temperature, suggesting that the accelerated diffusion at a higher temperature led to a 
higher probability of collisional quenching. Interestingly, the slope of fluorescence quenching 
was relatively independent of experimental temperatures. Further experiment is required to 
determine the mechanism underlying the Ca2+-induced fluorescence quenching of Calcein, 
such as investigating the effect of Ca2+ on the fluorescence lifetime of Calcein. 
In this work, the Ca2+-induced fluorescence quenching of Calcein is hypothesised to be 
achieved by the positive effect of Ca2+ on the aggregation of Calcein. It is known that Calcein-
Ca2+ interaction results in a complex with enhanced fluorescence. Therefore, the Ca2+-induced 
fluorescence quenching of Calcein was unlikely to be caused by static quenching, which 
resulted from the formation of non-fluorescent complex 202. At high Calcein concentration 
(>2mM), the increasing aggregation of Calcein induced the self-quenching of Calcein by 
enhancing the collisions between Calcein molecules.  As Ca2+ was added into the solution, Ca2+ 
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interacted with the Calcein and they form a fluorescent complex. However, when Ca2+ was 
much lower than Calcein (Ca2+/Calcein<0.5), a small amount of the fluorescent complex was 
formed, but only insignificant fluorescence was produced. Meanwhile, the interaction with 
Ca2+ alleviated the electrical repulsion between the negatively charged Calcein molecules, 
leading to the increased aggregation and a higher probability of collision. The self-quenching 
further enhanced under the higher collision rate. As the increased self-quenching surpassed the 
fluorescence enhancement, the overall trend of fluorescence change was quenching at this stage 
(Calcein > 0.5mM, Ca2+/Calcein < 0.5). As the ratio of Ca2+ to Calcein reached up to around 
0.5-1, the increasing amount of Ca2+-Calcein complex neutralised the self-quenching of 
Calcein and boosted the overall fluorescence intensity. Therefore, the increasing [Ca2+] 
diminished the fluorescence quenching (0.5 < Ca2+/Calcein < 1), followed by a significant 
fluorescence enhancement (Ca2+/Calcein > 1). 
Compared with the previous methods for serum Ca2+ quantification using Calcein, the method 
presented here did not require the dilution of the samples so that the measurement was 
simplified by mixing the ions sample and indicator solution. However, the alkaline working 
environment of Calcein would restrict its biological applications. 
By contrast, the application of Rhod-5N is well compatible with the physiological environment. 
In the presence of 0-2mM Ca2+, Rhod-5N displayed the significant fluorescence increase at 7.4 
pH (physiological condition). Moreover, Rhod-5N exhibited a high selectivity to Ca2+ over 
other metal ions that were commonly found in the interstitial fluid. Additionally, the optimal 
concentration of Rhod-5N (50μM) identified in this work was significantly lower than the 
micro-tip probe for [Ca2+]ex recording, where 3mM Rhod-5N was employed. Although Cu
2+ 
and Zn2+ were shown to suppress the Ca2+-induced fluorescence of Rhod-5N, interference from 
Cu2+ or Zn2+ was less likely to cause a major issue as their concentrations are relatively stable 
during biological events. If necessary, the Cu2+ and Zn2+ can be depleted by applying Zn2+ and 
Cu2+ chelators, such as N, N, N′, N′ -tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) or 
diethylenetriaminepentacetic acid (DPTA) 209,210.  
In conclusion, the comprehensive comparisons between Calcein and Rhod-5N suggested that 
Rhod-5N showed advantages over Calcein for sensing [Ca2+]ex in terms of fluorescent signal 
strength, indicator consumption, selectivity to Ca2+ and biocompatibility. Therefore, Rhod-5N 




Chapter 3   
 
Design, fabrication and characterisation of a microfluidic 
chip for tissue secretion analysis 
 
This chapter describes the fundamental fluidic physics at microscale that are essential to the 
rational design of a microfluidic chip and its prevalent fabrication using soft lithography. In 
order to develop a microfluidic device for tissue secretion analysis, a microfluidic chip was 
designed with the capabilities of manipulating the stimulation, immobilising tissues, 
fluorescent sensing and continuous collection of the tissue effluent. Both theoretical 
simulations and experimental tests were performed to characterise the fluid dynamics in the 
microfluidic chip, including the flow regime, mixing efficiency and input control. Tissue 
trapping efficiency was also studied by simulating the tissue loading with microspheres. 
 
3.1 Background 
3.1.1 Fundamentals of fluid dynamics at microscale 
To design and fabricate a microfluidic chip suitable for biological application, it is essential to 
know the correlation between the dimension of the micro-geometry of the chip and the fluid 
dynamics. In general, three fundamental aspects should be considered: (i) the concept of flow 
regime and different flow types; (ii) the diffusion feature of molecules in a microfluidic channel; 





Figure 3.1 | Three typical fundamental aspects of fluid dynamics in microscale channels. a | Fluidic 
features of laminar flow and turbulent flow 211; b | Molecules diffusion between two co-flow laminar flows, 
where the diffusion and mixing degree of two flows are enhanced with the increase of the co-flow length 212.  
c | Stick diagram of a microfluidic model where the arrows indicate the fluidic flow in each branch 213. 
 
3.1.1.1 Reynolds number and flow regimes 
Fluid regimes are classified into two major types, laminar flow and turbulent flow, based on 
the fluidic features (Fig. 3.1a) 214. Specifically, laminar flow consists of parallel flow streams, 
leading to highly stable and predictable fluid behaviours. On the contrary, the random 
fluctuation in turbulent flow produces unpredictable flow patterns such as eddies and vortices 
213. The fluid flow type in a pipe is determined primarily by a dimensionless quantity called 




     (𝐸𝑞. 3.1) 
where 𝜌 is the density of the fluid [kg/m3], 𝑣 is the average flow velocity [m/s], 𝐷ℎ  is the 
hydraulic diameter of the channel [m], 𝜇 is the viscosity of the fluid [kg/m•s]. The hydraulic 






     (𝐸𝑞. 3.2) 
where 𝐴 is the area of a cross-section of the channel [m2], 𝑈 is the wetted perimeter [m] 215. As 
shown in Table 3.1, the hydraulic diameter of a microfluidic channel can be further expressed 
based on the shape of the cross-section. 
 
Table 3.1 | The hydraulic diameter of different shapes of microfluidic channels 
Cross-section shape Parameter Hydraulic Diameter (Dh) 
Circle Radius (RC), diameter (d) 𝐷ℎ𝑐 =
4 • ᴨ • 𝑅𝐶
2
ᴨ • 𝑑
= 𝑑     (𝐸𝑞. 3.3) 
Square Length (l) 𝐷ℎ𝑠 =
4 • 𝑙2
4 • 𝑙
= 𝑙     (𝐸𝑞. 3.4) 
Rectangle Length (l), height (b) 𝐷ℎ𝑟 =
4 • 𝑙 • 𝑏
2 • (𝑙 + 𝑏)
=
2 • 𝑙 • 𝑏
𝑙 + 𝑏
     (𝐸𝑞. 3.5) 
 
According to the fluid mechanics, the flow is laminar if the Reynolds number is less than 2100, 
and is turbulent when the Reynolds number is greater than 4000 216. When the Reynolds 
number ranges from 2100 to 4000, the flow is described as transitional. Due to the microscale 
dimension of the channel and low fluidic velocity, flows in microfluidic chips generally have 
low Reynolds numbers and, therefore, are laminar.   
 
3.1.1.2 Molecules diffusion  
In the context of laminar flow, the mixing of molecules occurring in a microfluidic channel is 
predominantly dictated by diffusion. When mixing two solutions in a microfluidic channel, a 
group of molecules in the concentrated solution, by Brownian motion, spread out over time 
(Fig. 3.1b) 212. During the mixing process, the distance (d) that a molecule can travel is related 
to the diffusion coefficient (D) and the time for travelling (t). The relationship can be described 
as:  
𝑑2 = 2𝐷𝑡     (𝐸𝑞. 3.6) 
As shown in Table 3.2, D of molecules related to this work has been reported in the literature. 






     (𝐸𝑞. 3.7) 
where k is the Boltzmann constant, r is the hydrodynamic radius of the molecule. 
The diffusion in a microfluidic channel is a spreading process over time. The relationship 
between D and the mixing time (τ) to achieve the homogeneous distributions, and a channel 




     (𝐸𝑞. 3.8) 




     (𝐸𝑞. 3.9) 
where Q is the volumetric flow rate. The necessary length (L) for thorough mixing of the two 




     (𝐸𝑞. 3.10) 
As Eq. 3.10 suggests: (1) only fluids flow through channel length L, the concentrations of the 
molecules become constant across the entire cross-section of the channel (complete mixing); 
(2) the channel length L required for a complete mixing increases with an increasing ratio 
between the width and height of the channel or vice versa. 
 
3.1.1.3 Flow rate in the branched channels 
For microfluidic chips with constant flows driven by external pumps, the flow rate in each 
branched channel is determined by the mass conservation. As shown in Fig. 3.1c, three input 
flows of this conceptual microfluidic structure are pumped into the canals via port 1, 2, 4 (P1, 
P2, P4) with flow rates Q1, Q2 and Q4 respectively. Port 3 (P3) is set as the outlet. Based on the 
mass conservation law, the flow rates of the fluids, in this case, obey the following relationship: 
Q1 = Q5, Q2 = Q6     (Eq. 3.11) 




3.1.2 Fabrication of microfluidic device via soft lithography 
Soft lithography refers to the application of photolithography on manufacturing a two-part 
polymer (elastomer and curing agent), most notably PDMS, with photoresist master. Soft 
lithography enables the manufacture of chip structures with lateral dimensions of 1-1000μm 
and vertical dimensions from 100nm to hundreds of microns 218. The competency of precisely 
fabricating various structures at microscale has facilitated the development of various 
microfluidic devices for a wide range of biological studies. 
 
 
Figure 3.2 | The procedure of the fabrication of microstructures via soft lithography 218. a | A silicon 
wafer is prepared as the substrate; b | Light-sensitive photoresist is coated on the substrate; c | Proposed 
microstructure is written on the mask, which is placed on the photoresist; d | When exposed to UV light, the 
solubility of the photoresist changes and the unnecessary part is removed by the developer; e | PDMS is 
poured on the mould and cured to form the structure; f | A PDMS embossed with designed structure is 




The overall procedure of soft lithography is shown in Fig. 3.2. Once the proposed design of a 
chip is determined, the structure pattern is drawn in a computer-aided design (CAD) software. 
The pattern is then transferred onto a transparent mask by printing on a polymer matrix or 
laser/electron-beam writing on a glass substrate. The mask is then placed on the top of a silicon 
wafer (or glass slide) coated with a layer of photoresist (Fig. 3.2a-c). When exposed to UV 
light, the photoresist undergoes photochemical reaction, which affects the solubility of the 
photoresist. The light exposure makes the positive photoresist more soluble and the negative 
photoresist less soluble. Photoresist solvent, called developer, is then used to dissolve the 
radiated or non-radiated photoresist to form a master mould, which has the opposite pattern of 
designed structure (Fig. 3.2d). The as-prepared PDMS is poured onto the mould with the 
negative pattern. When PDMS is hardened through the curing process, it is peeled off and the 
microstructure is formed in the PDMS chip (Fig. 3.2e-f).  
Soft lithography represents a mainstream method for fabricating microfluidic devices due to 
the intrinsic advantages of PDMS, which is non-toxic to cells and permeable to biologically 
important gas. Moreover, PDMS is optically transparent and essentially soft and flexible 
compared with solid materials such as glass. The transparency of PDMS allows the applications 
of optical sensing methods, particularly the fluorescent sensing, without causing significant 
interference. With a remarkable advantage in replicating, the procedures of soft lithography 
can be accomplished in an ambient laboratory environment and no major expense will be 
produced once the master is patterned 219. Furthermore, the tunability of the surface properties 
of PDMS enables the adjustments of hydrophilicity and therefore the bonding capability of the 
PDMS chip to various materials.   
Considering the outstanding strengths of PDMS as discussed above, the microfluidic chip used 
in this work was fabricated with PDMS by soft lithography. 
 
3.2 Methods 
3.2.1 Design of the microfluidic chip  
The proposed design of the chip layout is shown in Fig. 3.3a. The microfluidic chip consisted 
of three inlets, where cell culture mediums would be loaded via the first two inlets and 
fluorescent indicator would be introduced through inlet 3. Following the inlets, two sections of 
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serpentine channels were implemented to increase the mixing efficiency of molecules in the 
solutions. To achieve the immobilisation of biological tissues (e.g. the pancreatic islets), a 
tissue array was incorporated within the first serpentine channel. Under the continuous 
perfusion, the effluent of the tissues would be collected from the tissue array and flowed into 
the downstream channel. The extracellular fluid was then mixed with the indicator solution in 
the second serpentine channel. Following the second serpentine channel, an optical window 
was built for fluorescence detection. The detailed criteria of the chip design were described as 
follow:  
                                                      
1) Double-input inlets.  Double-input system was designed for introducing stimulation 
in cell culture medium and fluorescent indicator via stimulation inlet and indicator 
inlet, respectively. The stimulation inlet consisted of two converged inlets, inlet 1 and 
inlet 2. The stimulation inlet was built in prior to tissue trapping to supply the tissue 
with refreshing medium and stimulation. The indicator inlet, inlet 3, was built beyond 
the tissue trapping site so that the fluorescent indicator(s) could be mixed with the 
effluent from the tissue for quantifying [Ca2+]ex. Meanwhile, building the indicator 
inlet after the tissue array would eliminate the interaction between the indicator and 
tissues, including the intake of indicator into the cells and the potential toxicity of the 
indicator imposed on tissues. 
 
2) Tissue trapping structure. As this chip was designed for investigating the insulin 
secretion from the pancreatic islet, structures for immobilizing islet tissues were 
required to be built in the chip. This work adopted the design of a tissue array for islet 
immobilisation. The tissue array consists of a column of U-shape cups, which showed 
the advantages in reducing the shear stress on the tissue and amplifying the secretion 
by adjusting the number of the cups 159,174. 
 
3) Mixing efficiency. In the stimulation inlet, two groups of cell culture medium 
containing different concentrations of stimulus, typically one of the inlets with 
glucose, could be pumped into the chip to controllably create the dynamic stimulation. 
To ensure the immobilised tissues to be exposed to identical stimulation, the complete 
mixing of mediums from inlet 1 and 2 was required before the mixture arrives at the 
tissue array. Therefore, serpentine channels were built into the chip design. The first 
one was built after the stimulation inlet to improve the mixing efficiency of 
61 
 
stimulatory molecules. The second serpentine channel was built post tissue array to 
enhance the mixing of the indicator solution with the effluent from the tissue array. 
 
4) Dimensions of channels and U-shape cups. The pancreatic islets would be loaded into 
the chip by injection via inlet 1 or 2. Once in the channel, the tissues flowed through 
the channel under the continuous injection until they were captured in the tissue array. 
As the size of islets varies from 40 to 200μm in diameter and the shapes are close to 
the sphere, the width and height of the microfluidic channel were proposed to be 
300μm and 250μm, respectively (Fig. 3.3b & c). For the tissue cups, the dimension 
was designed as reported in the literature 162,177, where the opening was 250μm and 
the narrow cross-section area was 45μm (Fig. 3.3e). With the proposed dimensions, 
the channels would allow the free movement of tissues without causing clogging and 
the cups would be able to effectively capture the tissue.  
 
5) The dimension of the optical window. An optical window with 500μm in diameter 
was incorporated after the second serpentine channel (Fig. 3.3d) for two reasons: (i) 
The diameter of the optical window was larger than the channel width so that it would 
be capable of containing a larger volume of the sample for detection of a higher 
fluorescent signal at the optical window; (ii) The optical window was not overly large 
to cause time delay in refreshing the sample inside. Detailed dimensions of mask 






Figure 3.3 | The layout and dimension of the microfluidic chip design. a | The overall layout of the 
microfluidic chip, which consisted of three inlets, two serpentine channels, a tissue array embedded in the 
first serpentine channel, an optical window and an outlet; b-e | The detailed dimensions of the chip structure. 
 
3.2.2 Theoretical simulation of the fluid dynamics 
To understand the flow regime in the proposed design, the Reynolds number was calculated as 
a function of the flow rate based on the proposed chip dimension and the equations in section 
3.1.1.1. By plotting the Reynolds number against the flow rate, the ranges of flow rates were 
identified as laminar flow, transitional flow or turbulent flow in the microfluidic channel. Then 
the theoretical lengths required for the thorough mixing of glucose, Ca2+ and insulin were 
calculated to understand the relationship between flow rate and mixing length for each of the 
molecule in a straight channel. The serpentine channel is not necessary if the required length 
is much shorter than the scale of a microfluidic chip under a common flow rate for biological 
63 
 
study (1-10µL/min). Otherwise, the serpentine channels are indispensable to facilitate the 
mixing. 
The fluid dynamics in the microfluidic channels were further simulated in COMSOL 5.3 
(COMSOL Multiphysics, Sweden) to understand the fluid dynamics. The geometry for the 
simulation study was imported from the mask design in AutoCAD. The computational fluid 
dynamic (CFD) simulation was performed using the ‘laminar flow’ model. Under the physical 
model section, an incompressible flow model was applied to the simulation under general 
environment pressure level of 1atm and the temperature of 293.15K, i.e. the general room 
condition. The material used in the study was defined as water, with a density of 1000kg/m3 
and a dynamic viscosity of 0.001Pa•s. The boundary conditions of inlet 1 and 2 were defined 
with a fluid velocity of 10μm/s, while the velocity at inlet 3 was set as 20μm/s in order to 
compare the accumulated velocity of inlet 1 and inlet 2 with inlet 3. The velocities were 
arbitrarily set for a preliminary understanding of the fluid dynamics. At the outlet, the pressure 
was set as 1atm (same pressure as the outlet is exposed to air) with suppressed backflow. The 
physics-controlled mesh was used for the mesh sequence type with a normal element size under 
the default setting.  
Taking into account the criterion factors and simulation output, the chip design was sent to Dr. 
Aliaa Shallan for fabrication via soft lithography under the supervision of A/Prof. Craig Priest 
at the Future Industries Institute, University of South Australia. Similar fabrication procedure 
can be found in their previous papers 220,221. 
 
3.2.3 Optical examination of the dimension of microfluidic channels 
To examine the dimensions of the fabricated microfluidic chip, an optical microscope 
(Olympus BX51, Olympus, Japan) was used to examine the overall outlook of the microfluidic 
channels and an optical profiler Contour GT-I (Bruker, Germany) was then used to measure 
the detailed dimension of the chip. The measurement type was VSI, which was suitable for 
measuring the sample thickness higher than 135nm with precision at nano-meter. In order to 
expand the view, 5× and 0.55 were applied on the objective and multiplier respectively. Three 
PDMS chip replicas were measured and the averaged values of the measurements were used 




3.2.4 Experimental characterisation of the fluid dynamics  
A microfluidic perfusion system was set up to investigate the fluid dynamics in the microfluidic 
chip as shown in Fig. 3.4. The perfusion system consisted of a microfluidic pump with three 
syringe drivers (NanoJet Stereotaxic Syringe Pump, Chemyx, USA), three 500μl glass syringes 
(SGE, Trajan, USA), Fluorinated ethylene propylene (FEP) tubing (1/16’' OD× .010’’, IDEX, 
USA), inverted optical microscope (Olympus IX73, Olympus, Japan) and a waste container. 
Syringes and tubes were connected by 10-32 female and male lure adapter (IDEX, USA). 
Syringes, tubes and PDMS chip were loaded with ethanol before each experiment to reduce 
the entrapment of bubbles and then rinsed with DI water for three times.  
To indicate the flow dynamics in the channel, a 10% food colouring solution was prepared by 
100μL diluting the red food colouring in 900μL DI water. To investigate the mixing efficiency 
of the channel, 0.5mg/mL Rhodamine-B (Sigma, USA) was prepared by dissolving 5mg 
Rhodamine-B in 10mL DI water. 
 
 
Figure 3.4 | Schematic of the experimental set up of the microfluidic perfusion system. Three syringes 
were connected to the PDMS chip via FEP tubes. The flow rates of the three syringes were controlled by a 
syringe pump. For fluid observation, the chip was placed on an inverted microscope. The outlet was 
connected to a waste container.  
 
3.2.5 Investigation of the particle trapping efficiency  
Blue polyethylene (PE) microspheres (Cospheric, USA) were used as tissue surrogates to 
investigate the efficiency of the tissue trapping structure. The microspheres with diameters in 
90-100μm were selected as they were similar to the pancreatic islets in size and density. The 
microspheres suspension was prepared as indicated by the protocol. Briefly, 250mg 
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microspheres were dispersed in 1mL 0.1% Tween 80 (Sigma, USA) and the suspension was 
further diluted 100 times into 2.5mg/mL with 0.1% Tween 80 as the final injection sample. 
Prior to the loading, the microfluidic chip was rinsed with DI water and placed on the inverted 
microscope. The microspheres were loaded into the microfluidic chip by injecting with a 200μL 
pipette via inlet 1, while inlet 2 and inlet 3 were blocked by connecting to the paused pump and 
the outlet was exposed to air. The microspheres were carried into the channel and further into 
the tissue array with the injection flow. 
 
3.3 Results and discussion 
3.3.1 Reynolds number 
With the proposed chip width (300μm) and height (250μm), the hydraulic diameter was 
determined based on Eq. 3.2 and 3.5: 




                                                                  𝐷ℎ =
4 × 𝑤 × ℎ
2 × (𝑤 + ℎ)
 
                                                                  𝐷ℎ =
4 × (0.3 × 10−3) × (0.25 × 10−3)[𝑚2]
2 × (0.3 × 10−3 + 0.25 × 10−3)[𝑚]
 
                                                                  𝐷ℎ = 2.72 × 10
−4[𝑚] 
In order to build up the relationship between flow rate and Reynold number, the volumetric 
flow rate Q [μl/min], which is commonly used in the microfluidic experiment, was transformed 
into the fluidic velocity v [m/s] in the proposed channel: 




                                                                  𝑣 =
𝑄 × 10−9 ÷ 60[𝑚3/𝑠]
0.25 × 10−3 × 0.3 × 10−3[𝑚2]
 
                                                                  𝑣 = 𝑄 × 2.22 × 10−4[𝑚/𝑠] 
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The Reynolds number in the proposed channel was further determined based on Eq. 3.1 and 
physical properties of water. The viscosity of water depends on the temperature: the viscosity 
is 1.004×10-3 [kg/m•s] at 20°C and 0.691×10-3 [kg/m•s] at 37°C.  
At 20℃, 




                                    𝑅𝑒(𝑇 = 20℃) =
1000 × 2.72 × 10−4 × 𝑄 × 2.22 × 10−4[𝑘𝑔/𝑚 • 𝑠]
1.004 × 10−3[𝑘𝑔/𝑚 • 𝑠]
 
                                    𝑅𝑒(𝑇 = 20℃) = 6.01 × 10−2 × 𝑄 
At 37℃, 
                                    𝑅𝑒(𝑇 = 37℃) =
1000 × 2.72 × 10−4 × 𝑄 × 2.2 × 10−4[𝑘𝑔/𝑚 • 𝑠]
0.691 × 10−3[𝑘𝑔/𝑚 • 𝑠]
 
                                    𝑅𝑒(𝑇 = 37℃) = 8.74 × 10−2 × 𝑄 
As shown in Fig. 3.5, Reynolds number in the proposed channel was plotted against the flow 
rate at different temperature. At 20°C, the flow in the microfluidic channel transformed from 
laminar flow to turbulent flow at a flow rate of 34.94mL/min, while the transiting flow rate for 
37°C was 24.03mL/min. As the usual flow rate in a microfluidic device is at the scale of 
microliter per minute, the fluid in the proposed microfluidic chip would typically be laminar 





Figure 3.5 | The Reynolds number of fluid in the proposed design as a function of flow rate. Black and 
red lines indicate the Reynold numbers at 20°C and 37°C respectively. The area under the blue is defined as 
laminar flow, while the area between the blue line and green line indicates the transitional flow. Flows are 
turbulent if the Reynolds number is in the area above the green line. 
 
3.3.2 Molecules diffusion 
As the flow was typically laminar in the proposed design, the mixing of the two co-flow 
solutions relied on the diffusion of the molecules as above mentioned. It is important to know 
the channel length to reach a homogeneous distribution of the molecules across the channels. 
In this case, glucose was the molecule of interest as it would be used as the stimulus for future 
biological experiments. Therefore, the calculated channel length for glucose molecule was 
expected to be shorter than the practical distance from inlets to tissue array in the design, so 
that all the tissue in the arrays would be exposed to the same concentrations of glucose. 
Based on Eq. 3.9 and D [cm2/s] of the molecules (Table3.2), the relationship between the 
required mixing length for each molecule and the flow rate Q [μL/min] was expressed as: 
                                                   𝐿 ≈
𝑄𝑤
ℎ𝐷
       
                                                   𝐿 ≈
𝑄 × 10−9 ÷ 60 [𝑚3/𝑠]  × 0.3 × 10−3[𝑚]




                                                   𝐿 ≈
𝑄 × 10−6
5 × 𝐷
[𝑚]     (𝐸𝑞. 3.13) 
 
Table 3.2 ǀ Diffusion coefficients for key molecules in this study 
Molecule Molecular weight (Da) Diffusion coefficient (cm2/s) Ref. 
Glucose 180.16 6.7×10-6 222 
Ca2+ 40.08 7.9×10-6 223 
Insulin (bovine) 5733.49 7.3×10-7 224 
Rhodamine-B 479.02 4.2×10-6 225 
 
As shown in Fig. 3.6, the required mixing length for the three relevant molecules were plotted 
against the flow rates in the perfusion channel. To visualise the mixing length for the three 
molecules, the length of half a common glass microscopic slide (3.5cm) is shown as the green 
line. In a microfluidic channel without any mixing structure, 5.9cm length of the channel was 
required for a complete mixing of glucose at a flow rate of 2μL/min (pink line), which was 
almost the minimal flow rate for secretion study. Accordingly, the channel of the microfluidic 
chip would be over the scale of a glass slide if the mixing mechanism only relied on the 
diffusion of the molecules. Thus, the results justified the need for incorporating the serpentine 
channels into the microfluidic channel to improve the mixing. The incorporation of serpentine 
channels would not only extend the distance that the molecules travel through, but also would 
enhance the mixing of two co-flowing solutions via centrifugal forces when they pass the 






Figure 3.6 | The required mixing length for three relevant molecules as a function of flow rate. The 
mixing lengths of insulin, glucose and Ca2+ are shown in blue, black and red lines, respectively. The red line 
shows the basal length for the mixing of glucose in the secretion study, while the green line indicates the 
length of half a microscopic slide. 
 
3.3.3 Computational fluidic dynamics (CFD) simulation  
Fig. 3.7 shows the initial velocity settings and the velocity profile in the simulation. The 
boundary conditions of inlet 1, inlet 2 and inlet 3 were set as initial flow velocities of 10μm/s, 
10μm/s and 20μm/s (arbitrary value), respectively (Fig. 3.7a).  The overall simulation displayed 
a typical velocity profile of a laminar flow, where the fluid velocity was highest in the channel 
centre and dropped down to zero at the wall. The velocity mapping indicates that the 
distribution of the velocity is consistent with the conservation of mass (Fig. 3.7b). 
𝑣1 + 𝑣2 = 𝑣4 = 𝑣5 = 𝑣3 
𝑣6 = 𝑣3 + 𝑣5 = 𝑣3 + 𝑣1 + 𝑣2 
Notably, at the bottom half of the serpentine channel (indicated by the red arrow in Fig3.7b) 
where the tissue array was embedded in, the velocity was significantly smaller than the 
neighbouring main channel, suggesting that a significant amount of fluid was flowing through 
the tissue cup. The zoom-in view of the U-shape cups indicates the occurrence of a substantial 
partial stream (Q2) and a mainstream flow (Q1) when the flow passes through the tissue array. 
When the tissues are flowing in the channel, the individual tissue could be guided to occupy 
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the cups under the sequential effects of Q2 and Q1. As the perfusion system would be running 
continuously, the partial flow stream and the higher flow velocity at the narrower cross-channel 
section (indicated by the red arrow in zoom-in inset figure) would stabilise the tissue in the 
trapping site under hydrodynamic force 162 (Fig. 3.7c). 
 
 
Figure 3.7 | Computational fluidic dynamics (CFD) simulation on COMSOL. a | The simulation 
geometry and initial flow velocity at inlet 1 (10μm/s), inlet 2 (10μm/s) and inlet 3 (20μm/s). The velocity 
was set by arbitrary units; b | The velocity mapping of the microfluidic channel; c | A close-up view at the 
tissue cups, where the flow is separated into a main stream (Q1) and a partial stream (Q2). The red arrow 
highlights the higher velocity at the cross-section area. 
 
3.3.4 Dimension of the microfluidic geometry 
The overall outlook of the microfluidic channels is shown in Fig. 3.8i. The PDMS chips 
fabricated through soft lithography displayed well-defined microfluidic channels (Fig. 3.8a-f) 
which were highly consistent with the mask design on AutoCAD (Fig. 3.3a).  
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A major challenge in fabricating this microfluidic device was to preserve the narrow cross 
channel section, which was 40μm in width and much smaller than the main channel (300μm in 
width). Therefore, a proper developing time for dissolving the PDMS was critical as under-
development of PDMS would lead to residue sticking to the wall and over-development of 
PDMS would cause damage to the channel structure. As shown in Fig. 3.8c, the tissue array 
displayed no residues in the arc of the cup or damage caused by over-development. Moreover, 
the multiple trapping cups were accurately aligned, suggesting the fabrication protocol 
produced a minimal distortion to the micro-pattern. Similarly, the 3D simulated images of the 
microfluidic channel show that the microstructures were highly preserved in the fabricated chip 
(Fig. 3.8g & h). 
 
 
Figure 3.8 | The appearance of the microfluidic chip examined by optical microscope and optical 
profiler. a-f | The overall outlook of the channel examined by an optical microscope is clean and highly 
consistent with the mask design, suggesting the soft lithography well preserved the micro-pattern when 
translating the design into a PDMS chip; g-h | 3D simulated images based on the measurement of optical 
profiler indicate that soft lithography produced smooth channel surfaces throughout the PDMS chip. The 3D 
structure of the design was highly preserved in the fabricated devices; i | Outlook and size of the microfluidic 
chip in comparison with a coin (one Australian dollar). The chip consisted of a PDMS chip with embedded 




To precisely examine the dimension of the PDMS chip, the size of microfluidic structures 
measured by the optical profiler was compared with the original mask design. As shown in 
Table 3.3, the dimensions of the PDMS chip displayed a trend to undergo shrinkage in general. 
There were two reasons that can contribute the shrinkage. Firstly, the PDMS was poured into 
the mould to form the structure, thus it was normal that the dimension of the final PDMS chip 
was smaller than the mould. Secondly, the curing process in the mould was performed by 
incubation at 70°C so the PDMS was likely to undergo physical shrinkage when it cooled down 
to room temperature (thermal expansion coefficient of PDMS: 300×10-6 °C-1) 227. 
Comparing the errors in relatively larger structure with the smaller ones, the PDMS chips 
showed smaller errors (<10%) in the larger geometries, as reflected by the width and height of 
the main channel, the opening and base of the tissue array. However, the chips exhibited much 
higher errors (~25%) in the smaller structure, including the walls and cross-channel sections 
and of the tissue cups (Table 3.3). The larger errors in the smaller structure reflected the 
difficulties in fabricating the structures with tens of micrometres within the major channels at 
dimensions of hundreds of micrometres.    
 
Table 3.3 ǀ Comparison of the dimensions of the design and fabricated device 
Structure 
Main channel Tissue array 
Width Height Opening Wall Cross-channel Base Body 

















Error (%) 3.7 5.6 5.68 25 23.56 9.3 9.40 
 
3.3.5 Fluid dynamics in the microfluidic channels      
To experimentally characterise the fluidic behaviours in the microfluidic channel, manipulation 
of input solution and mixing efficiency of molecules in the channel were investigated. The 
former indicates the capability of producing a dynamic culture environment for the tissues, 
while the latter defines the flow rate range, within which all the tissues in the trapping site 
would be exposed to homogeneous stimulations. Without the addition of serum or other sources 
of protein, the density and viscosity of PBS and cell culture medium are not significantly 
different from the properties of water. Based on Eq. 3.1, the Reynold number of PBS or cell 
culture medium should be essentially similar to water. Therefore, DI water was used in the 
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experimental characterisation and the results are sufficient to reveal the fluidic dynamic of PBS 
or cell culture medium.  
3.3.5.1 Input manipulation 
The manipulation of input was achieved by modifying the ratio of flow rates at the inlet 1 and 
inlet 2. In this experiment, food colouring and DI water were pumped into the channel via inlet 
1 and inlet 2, respectively. When adjusting the ratio between the two flow rates (from 9:1 to 
1:9), different concentrations of the food colouring were produced in the microfluidic device. 
As shown in Fig. 3.9, the width of the food colouring flow decreased as the ratio between the 
flow rates of food colouring to water decreased. The differences in the width of food colouring 
flow resulted in serial diluted concentrations of food colouring from 0.9 to 0.1 of the original 
concentration of the colouring pumped via inlet 1. The results indicated that, in the future, a 
wide range of stimulus concentrations can be achieved by switching the flow rates ratio 
between the two inlets, where two solutions containing different concentrations of stimuli are 
pumped into the channel.   
 
 
Figure 3.9 | Experimental of analysis of input manipulation to achieve different final concentrations 
of food colouring. Food colouring and DI water were pumped into the microfluidic channel via inlet 1 and 




3.3.5.2 Mixing efficiency 
The mixing efficiency of the microfluidic chip was examined by the distribution of the 
colouring molecules upon the arrival at the tissue trapping site. Either food colouring or 
Rhodamine-B was pumped into the microfluidic channel with DI water via inlet 1 and inlet 2, 
respectively, at a flow rate ratio of 1:1 (Fig. 3.10a & d). Based on Eq. 3.9 and 3.10, a higher 
flow rate or a larger molecular radius would lead to a longer length to achieve a homogenous 
distribution of the molecules.  
Fig. 3.10b shows that the flow rate of food colouring at 8μl/min (or lower) produced a 
homogeneous distribution of molecules before the flow reached the tissue array. When the flow 
rate increased over 8μl/min, uneven concentrations of food colouring were observed across the 
channel at the trapping site. The heterogeneous distribution was particularly apparent when the 
flow rate reached 14μl/min (Fig. 3.10c), suggesting the mixing of dye molecules was 
incomplete and the concentration of the colouring was varying in each cup.  
As the diffusion coefficient of food colouring was not clear, Rhodamine-B (known diffusion 
coefficient, Table 3.2) was introduced into the channel via stimulation inlet so that the 
maximum flow rate for glucose could be calculated based on the mixing efficiency of 
Rhodamine-B.  
For Rhodamine-B, as the molecular radius was larger than the radius of food colouring 
molecule, heterogeneous distribution (insufficient mixing) of the Rhodamine-B in the 
microfluidic channel was observed with flow rate even low to 6μl/min (Fig. 3.10g-i). 
Specifically, the concentration of Rhodamine-B was higher at the side with the opening of the 
cup and lower at the wall side (Fig. 3.10h). As a result, flows in the first two cups (indicated 
by the dashed rectangle) were exposed to much higher concentrations of the dye compared 
with the following cups. Alternatively, if the inlet for Rhodamine-B swapped with the inlet 
with water, the concentration of Rhodamine-B was lower at the opening side, leading to much 
lower concentrations of Rhodamine-B in the first few cups (Fig. 3.10i). In contrast, complete 
mixing of Rhodamine-B upon reaching the trapping site was achieved with the flow rate at 





Figure 3.10 | The mixing efficiency of food colouring and Rhodamine-B at different flow rates in the 
microfluidic chip. Flow rates shown above each panel indicates the corresponding total flow rate of inlet 1 
and inlet 2. a | Food colouring and DI water were pumped into the microfluidic chip via inlet 1 and inlet 2. 
The ratio of the flow rates at the two inlets was 1:1; b | Homogenous distribution of food colouring was 
achieved prior to the tissue array when the total flow rate of inlet 1 and inlet 2 was lower than 8μL/min; c | 
An incomplete mixing of food colouring was observed when the flow rate reached 14μL/min; d | Rhodamine-
B and DI water were pumped into the microfluidic chip via inlet 1 and inlet 2 at the flow ratio of 1:1; e – f | 
Homogenous distribution of Rhodamine-B was achieved prior to the tissue array when the flow rate was 
3μL/min or lower; g – i  | Heterogeneous distribution of Rhodamine-B were observed as the flow rate reached 
up to 6μL/min. The dashed rectangle shows the dye concentrations significantly different from the following 
cup if the mixing is incomplete. 
 
At a given channel length L from inlet to the tissue array, the maximum flow rate for ensuring 
a sufficient mixing of a molecule is expressed based on Eq. 3.10:  






Therefore, the relationship between the maximum flow rate for glucose QG and Rhodamine-B 
QR can be written as: 
















     (𝐸𝑞. 3.14)      
The diffusion coefficient of glucose and Rhodamine-B are 6.7×10-6cm2/s and 4.2×10-6cm2/s, 
respectively. The maximum flow rate for glucose was calculated as:  
                                                        𝑄𝐺 ≈
6.7 × 10−6
4.2 × 10−6
× 𝑄𝑅 = 4.77[𝜇𝐿/𝑚𝑖𝑛] 
With the fixed length from inlet to tissue array, the maximum flow rate from the stimulation 
inlet was estimated to be around 4.77μL/min to allow a homogeneous distribution of glucose 
across the channel upon reaching the tissue array. It is worth noting that the perfusion 
experiment in this section was conducted at room temperature 23°C (296.15K). In the future 
biological experiment, the perfusion system would be heated up to 37°C (310.15K). Therefore, 




     (𝐸𝑞. 3.7) 










       
             𝑄𝐵 = 1.047 × 4.77[𝜇𝐿/𝑚𝑖𝑛]    
             𝑄𝐵 = 5[𝜇𝐿/𝑚𝑖𝑛]                           
Therefore, complete mixing of glucose can be ensured at the tissue array when the total flow 
rate of inlet 1 and inlet 2 is 5μL/min at 37°C. As glucose is the most prevalent stimulus in islet 
study, 5μL/min would be used as the flow rate in Chapter 4 to characterise the sensing 
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performance of the system so that the characterisation will have biological implications for the 
applications in pancreatic islets.  
 
3.3.6 Particle trapping efficiency of the tissue array 
To simulate the loading procedure of pancreatic islet, the particle trapping experiment was 
performed to investigate the trapping efficiency of the tissue array. Notably, the actual size of 
the beads varies from 45-90μm in diameter, which was smaller and more heterogeneous than 
the size in the product information (90-100μm). As the beads loading was achieved by manual 
injection with a 200μL pipette, the flow rate, instead of giving an accurate value, would be 
described as slow if the 200μL was injected within a few minutes or fast if the injection was 
completed in tens of seconds.  
As shown in Fig. 3.11b, the beads were successfully captured by the tissue array after their 
loading via injection at inlet 1 with a slow flow rate. By optimizing the concentration of the 
microspheres at 2.5mg/mL, nearly every cup was occupied by a single bead. When extending 
the loading time (slow flow rate), the beads were continuously captured by the tissue array (Fig. 
3.11d-f). It was interesting to note that the beads delivered by this flow rate were all stacked in 
the cups without leakage before the cup was full. In contrast, beads immobilised in the cup 
were shown to be pushed out of the cup under fast injection (Fig. 3.11c), suggesting the fast 
injection resulted in higher hydraulic pressures in the cups. These observations suggested that 
apart from the loading time, the injection speed or flow rate (corresponding to the localised 
pressure in the cups) affected the loading efficiency. More importantly, all experimental results 
indicate that, in the U-shape cups, the partial flow Q2 lead to the effective guidance of beads 





Figure 3.11 | The trapping efficiency of the tissue array with micro-beads (45-90μm in diameter). a | 
Microfluidic channel perfused with water; b | Micro-beads were loaded into the tissue array and trapped in 
the cups via manual injection through a 200μL pipette; c | The beads were pushed out the cups during fast 
injection; d-f | The number of beads in each cup increased in the continuous loading. The black arrow points 
out a bubble that was trapped during the experiment. 
 
3.4 Discussion 
In this chapter, the microfluidic chip aimed for detecting [Ca2+] and secretion analysis was 
designed, fabricated and characterised. The microfluidic chip consisted of stimulation inlets, 
serpentine channels, tissue array, indicator inlet and outlet. Driven by the ultimate goal of 
investigating the role(s) of [Ca2+]ex in the secretion of insulin, the microfluidic chip was 
designed to be capable of controlling culturing environment of tissues, continuously extracting 
the extracellular fluid, introducing fluorescent Ca2+ indicator, detecting [Ca2+]ex and collecting 
samples for insulin quantification.  
Prior to the chip fabrication, the rationales of the design were examined by the fluidic dynamics 
simulation (based on the related fluidic physics). The Reynolds number calculation confirmed 
the laminar flow in the proposed device. The diffusion calculation for glucose suggested that 
the molecule diffusion was insufficient for a complete mixing upon reaching the tissue array, 
which justified the necessity to integrate the serpentine channels for enhancing the mixing 
efficiency. The CFD simulation indicated that substantial partial flow was flushing through the 
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U-shape cups, enabling the capture of tissues and continuously refreshing the extracellular 
environment. 
The proposed microfluidic chip was then manufactured by soft lithography with PDMS. The 
overall outlooks of the fabricated PDMS chips displayed a well-structured microfluidic channel, 
which was highly consistent with the mask design. Certain fabrication errors (the physical 
dimension of the chips smaller than the design) were found in the as-fabricated PDMS chips, 
which were majorly due to the shrinkage property of PDMS during curing. However, as the 
dimensions of fluidic channels (hundreds of microns) and cross-section area of U-shape cup 
(down to tens of microns) were significantly different, varying deviations (<10% for large 
structure and around 20% for smaller structure) were observed in different structures of the 
chip.  
Pilot experiments of simulating the loading of pancreatic islets by micro-beads demonstrated 
the capability of the tissue array to efficiently capture the micro-scale objects in the 
microfluidic channels. With the diluted beads suspension and relatively short injection time, 
the optimal loading was achieved as a single bead was captured in each cup. However, if the 
suspension was over-injected into the channel, it was challenging to achieve the optimal 
trapping as the beads tended to stack in the cups until they filled the cup. Moreover, the beads 
were shown to be pushed out of the cup under fast injection due to the higher pressure imposed 
on the beads in a faster flow. Nevertheless, the loading of pancreatic islets is expected to be 
promising based on the loading experience on microspheres. Firstly, the sizes of mammal 
pancreatic islets for loading can be selected between 150 and 200μm 228 in diameter so that 
only one tissue would be trapped in a cup. Therefore, the rest of the tissues in the channel will 
be guided into the following cup. Secondly, it is unlikely to push the trapped islets out of the 
cups considering the selected sizes will be significantly larger than the microspheres (45-90μm 
in diameter) used in the simulation. 










Demonstration of the microfluidic system for simultaneous 
monitoring of [Ca2+]ex and insulin 
 
This chapter demonstrates the feasibility of utilising this microfluidic sensing system for 
simultaneous monitoring of [Ca2+] and insulin. Firstly, the microfluidic system was 
incorporated with a LIF detection system to establish the standard curve of the fluorescent 
signal as a function of [Ca2+]. Secondly, the simultaneous monitoring of [Ca2+]ex and insulin 
was achieved by correlating the Ca2+-induced fluorescent signals with insulin concentration 
determined by ELISA. The results suggested that the on-chip fluorescence measurements were 




As the aim of this sensing platform is to achieve the simultaneous monitoring of [Ca2+]ex and 
insulin, quantitative method for measuring the concentration of insulin is required to be 
incorporated into the system. For the microfluidic devices developed for islet study, ELISA is 
the prevalent method for insulin quantification 151.  
ELISA is a biochemical assay that utilises antibodies and the enzyme-induced colouration to 
measure the presence or concentration of either antigen (peptides, proteins, hormones, etc.) or 
antibody in biological fluids 229. There are four major principles in ELISA protocols, i.e., direct 
ELISA, indirect ELISA, sandwich ELISA and competitive ELISA 230. Generally, ELISAs 
work in 96-well microplates with the fluid samples isolated from the objects. 
81 
 
For direct ELISA, a molecule of interest, antigen in this case, in the sample is absorbed onto 
the surface of the assay plate via non-specific binding. Enzyme-conjugated primary antibody 
is then added into the system and incubated with the immobilised antigen. On the completion 
of the incubation, the well is washed to remove the unbound antibody. Subsequently, the 
enzyme substrates are added into the well, where the substrates interact with the enzyme and 
undergo colouration. The latter is dependent on the bound enzyme. The concentration of the 
antigen is further determined by measuring the optical density (OD) of the sample (Fig. 4.1a). 
In the indirect ELISA, the plate surface is pre-coated with antigen, which specifically reacts 
with the primary antibody (target molecule in this case) in the sample. The enzyme-conjugated 
secondary antibody is then added into the plate and binds to the primary antibody. The 
concentration of the primary antibody is further read out by the colouration of the substrates 
induced by the bound secondary antibody (Fig. 4.1b). In the sandwich ELISA, the target 
antigen is trapped between the primary antibody and the enzyme-conjugated secondary 
antibody, where a sandwich-like structure is formed (Fig. 4.1c). In the competitive ELISA, 
samples containing the target antigen are mixed with enzyme-tagged antigen and then added 
into a microplate coated with antibody. The untagged antigen (from the sample) competes with 
the tagged antigen to bind with the antibody (Fig. 4.1d). The unbound antigen is removed and 
substrates are added into the system to quantify the bound enzyme-tagged antigen. In this case, 
the concentration of the untagged antigen (molecule of interest in this case) has a negative 
correlation with the optical signal, as the more antigen in the sample, the less enzyme-
conjugated antigen can bind to the antibody to induce the colouration of the substrates. 
ELISA represents a reliable method for protein quantification as it is highly sensitive and 
selective to the molecules of interest 230. Moreover, all the components for ELISA have been 
assembled into a portable kit that is ready-to-use. It allows multiple measurements (over 80 
samples per kit) with low requirement on experimental facilities (only a plate reader for 
measuring OD). Therefore, ELISA is used in this study to quantify the insulin concentrations 





Figure 4.1 | Schematics of the four major types of ELISA. a | In the direct ELISA, the antigen is absorbed 
onto the plate surface via non-specific binding. The enzyme-tagged antibody is then added into the system 
to induce a dose-dependent colouration of the substrate. The concentration of the antigen is revealed by the 
degree of the colouration; b | In indirect ELISA, the plate surface is pre-coated with the antigen that 
specifically reacts with the target antibody. When the antibody in the sample binds to the antigen, the 
enzyme-tagged secondary antibody (orange) is added into the system. The bound enzyme induces the dose-
dependent colouration of the substrate, which is further used to analyse the concentration of target antibody; 
c | In sandwich ELISA, the target antigen is trapped between the primary antibody coated on the plate surface 
and the enzyme-tagged secondary antibody. Therefore, they form a sandwich-like structure; d | In 
competitive ELISA, the target antigen in the sample competes with the enzyme-tagged antibody to bind to 
the antibody. The more antigen in the sample, the less enzyme-tagged antibody can bind to the antibody, 
leading to a less extent of colouration. Thus the concentration of target antigen is negatively correlated with 
the degree of colouration.      
 
4.2 Methods 
4.2.1 In-house built microfluidic sensing system 
To measure the dynamic fluorescence intensity in the microfluidic chip, a LIF detection system 
was incorporated with the microfluidic perfusion system as shown in Fig. 4.2a. As Rhod-5N 
has been identified as the indicator to monitor the dynamic Ca2+ in biological samples, 532nm 
laser generator (MatchBox, Integrated Optics, Lithuania) was employed as the light source, 
which was guided by a bifurcated fibre (FG200UEA, THORLABS, USA) to the PDMS chip. 
The optical signal of Rhod-5N in response to [Ca2+] was collected and delivered by the other 
branch of the fibre to the spectrometer (QEPro, Ocean Optics, UK). The tip of the bifurcated 
fibre underneath the PDMS chip was coupled by a focusing lens. A 532nm long-pass filter 
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(THORLABS, USA) was placed before the spectrometer (to remove the scattering light 
interference (Fig. 4.2b). As shown in Fig. 4.2c, the PDMS chip attached on a glass slide was 
mounted on an in-house fabricated aluminium framework as a slide holder (Fig. 4.2d) for 
mechanical stability. The position of the slide holder can be controlled precisely in a step-wise 
manner by the micro-stepper (LST-15FC60-40R-XYZ, Lambda Scientific).  
 
 
Figure 4.2 | Schematics of the in-house built microfluidic sensing system. a | The microfluidic perfusion 
system was incorporated laser-induced fluorescence detection system based on a bifurcated fibre; b | The 
major optical components, including laser, filter, shutter and spectrometer, were equipped on a board, 
enabling a portable detection system; c | The glass slide was connected to the position adjuster via an 




The open and closure of shutter, as well as the detection of the spectrometer, were controlled 
by the LabView program developed by Dr. Erik Schartner. Briefly, once the laser beam was 
on, the shutter closed to block the light. When clicking at the ‘read’ button on the computer, 
the shutter opened, the laser passed through the shutter and excited the fluorescent indicator in 
the chip. The emitted fluorescence from the indicator was collected by the fibre and, 
subsequently, sent to the spectrometer for detection. The shutter closed again once a fluorescent 
signal was detected. The closure of shutter during the non-detection period effectively avoided 
the photobleaching of the indicator induced by continuous exposure. 
 
4.2.2 Preparation of fluorescent Ca2+ indicator and artificial extracellular fluid 
As discussed in Chapter 2, Rhod-5N has been identified for the optimal indicators to track the 
Ca2+ concentration. The 1mM stock solution of Rhod-5N was prepared by dissolving 500μg 
Rhod-5N powder (Thermo Fisher Scientific, USA) in 555.6μL pH7.4 PBS buffer. The stock 
solution was subsequently diluted into 100μM with pH7.4 PBS buffer for measuring Ca2+ 
concentration. PBS buffer was freshly prepared before preparing the Rhod-5N solutions as 
described in section 2.2.2 with freshly calibrated pH meter for adjusting the pH. 
Dulbecco’s Modified Eagle Medium (DMEM) (Thermo Fisher Scientific, USA), is a cell 
culture medium that is widely used in in vitro cell/tissue culture. To simulate the measurement 
of [Ca2+]ex
 in a biologically relevant environment, Ca2+-free cell culture medium, was used to 
as the base medium for preparing Ca2+ solution.  
The 200mM Ca2+ stock solution was diluted into 2mM and 4mM respectively. The 4mM Ca
2+ 
DMEM was subsequently 1:1 mixed with a standard insulin sample to obtain an insulin-
supplemented DMEM for the simultaneous measurement of Ca2+ and insulin. In this 
experiment, the Calibrator 5, containing 200mU/L insulin, from the insulin ELISA kit 
(Mercodia, Sweden) was used to mix with the 4mM Ca2+ DMEM to prepare the insulin-
supplemented cell culture medium, where the final concentrations of insulin and Ca2+ were 




4.2.3 Perfusion arrangements of the on-chip measurements 
To characterise the on-chip fluorescent sensing of the system, two on-chip experiments were 
carried out as proof-of-concept experiments: (i) Standard curve of the fluorescence intensity as 
a function of [Ca2+]; (ii) Demonstrate the feasibility of utilising this sensing platform for 
simultaneous measurements of [Ca2+] and insulin. 
The perfusion settings for the two experiments are shown in Fig. 4.3. Generally, two cell culture 
mediums containing varying concentrations of Ca2+ or insulin were pumped into the 
microfluidic chip via inlet 1 and inlet 2 respectively. While the total flow rate of inlet 1 and 
inlet 2 was maintained constant, the ratio of inlet 1 to inlet 2 (RI) was switched to obtain serial 
concentrations of Ca2+ in the channel. The flow rate at inlet 3 was set the same as the total flow 
rate of inlet 1 and inlet 2. These sensing conditions replicated the off-chip measurements, where 
the Ca2+ solution was 1:1 mixed with the indicator solution. The detailed flow rates settings for 
the two experiments are described in the following two sections, respectively. 
In Chapter 2, the Ca2+ sample was 1:1 mixed with indicator solution in a well for fluorescence 
measurement. The concentrations of Ca2+ used in the results were the final Ca2+ concentrations 
(detecting concentrations) in order to demonstrate the sensing performance of the indicator 
when they were dissolved in the extracellular fluid. In this chapter, Ca2+ concentrations in the 
samples (sample concentrations of Ca2+ before mixing with the indicator) are used in the results 
to demonstrate the sensing performance of the system in revealing the dynamic changes of Ca2+ 
in the effluents from the tissue array. Therefore, the concentrations of Ca2+ in this chapter are 
equivalent to twice the Ca2+ concentrations in Chapter 2. For example, the fluorescence of 
Rhod-5N induced by 0-2mM Ca2+ in the results of this chapter is equivalent to the fluorescence 
induced by 0-1mM Ca2+ in Chapter 2. Thus, the standard curve of fluorescence intensity in 
response to 0-3mM [Ca2+] (sample concentration) established in the following section (4.2.4) 
is then further compared with the fluorescence intensity induced by 0-1.5mM Ca2+ (detecting 
concentration) in the off-chip measurements via plate reader. (The difference between sample 





Figure 4.3 | The experimental settings for the perfusion solution in the two following experiments. Two 
cell culture medium containing varying concentrations of Ca2+ were pumped into the channel via inlet 1 and 
inlet 2. While the total flow rate of inlet 1 and inlet 2 were constant, the ratio of the flow rate at inlet 1 to 
inlet 2 was altered to obtain serial concentrations of Ca2+ in the channel. The Rhod-5n solution was pumped 
into the channel at inlet 3 at the same flow rate as the total flow rate of inlet 1 and inlet 2. 
 
4.2.4 On-chip establishment of fluorescence standard curve as a function of [Ca2+] 
Considering the volume and motions, the fluorescence intensity measured from samples 
flowing in a microfluidic channel can dramatically vary from the fluorescence of the samples 
in a microplate. Thus, it was important to establish a standard curve of the fluorescence 
intensity of the indicator as a function of [Ca2+] to characterise the on-chip fluorescence profile. 
In this experiment, 4mM Ca2+-supplemented DMEM was used as the Ca2+ fluid in order to 
establish a standard curve of 0-3mM Ca2+ in the sample, which fully encompassed the target 
Ca2+ (0-2mM) (Fig. 4.3 bottom, Perfusion setting 1). As shown in Table 4.1, the flow rates of 
inlet 1 and inlet 2 were switching between 0-4μL/min with a total flow rate of 4μL/min, which 
was also the flow rate at inlet 3. The flow rates used in this experiment were arbitrarily set 
within the flow rate range of future biological application (0-5μL/min). The fluorescence 
intensities at 580nm (fluorescence peak of Rhod-5N) in response to varying Ca2+ 
concentrations were recorded. Each measurement was repeated three times with an interval of 
30 seconds. When adjusting the flow rate for a different [Ca2+], the fluorescence was recorded 




Table 4.1 ǀ Flow rate setting and corresponding sample concentration of Ca2+ 
[Ca2+]S (mM) 
Flow Rate (μL/min) 
RI 
Inlet 1 Inlet 2 Inlet 3 Outlet 
0 4 0 4 8 4 : 0 
0.5 3.5 0.5 4 8 7 : 1 
1.0 3 1 4 8 3 : 1 
1.5 2.5 1.5 4 8 5 : 3 
2.0 2 2 4 8 1 : 1 
2.5 1.5 2.5 4 8 3 : 5 
3.0 1 3 4 8 1 : 3 
 
4.2.5 Development of a dual-sensing system for [Ca2+]ex and insulin secretion 
To simultaneously record the [Ca2+]ex and insulin concentration, Ca
2+-free DMEM and 2mM 
Ca2+ DMEM supplemented with 100.5mU/L insulin were pumped into the channel via inlet 1 
and inlet 2, respectively (Fig. 4.3 bottom, Perfusion setting 2). Prior to pump the samples, the 
microfluidic channel was rinsed with 0.3% bovine serum albumin (BSA) for 15 minutes to 
prevent the non-specific absorption of insulin by PDMS. The 0.3% BSA was prepared by 
dissolving 0.15g BSA (Sigma, USA) in 50g DI water in a clean Falcon tube. 
In this experiment, the flow rates of inlet 1 and inlet 2 were dynamically controlled to produce 
oscillatory [Ca2+] (1.0-1.8mM, 0.5-1.5mM and 0.2-1.0mM, respectively) and oscillating 
insulin concentrations as detailed in Table 4.2. The experiment time of each concentration 
group last for 30 minutes, during which the fluorescence intensity was recorded in every 10 
seconds. 
In a biological experiment, homogeneous distributions of stimulatory molecules must be 
achieved on the tissue array in order to equally stimulate the 10 tissues in the tissue array. As 
a result, the applicable flow rate range is determined by the stimulus used in the experiment. 
Glucose is the most prevalent stimulus used in islet studies and, therefore, it was used as the 
reference for deciding the flow rate to be used in the following experiment. As discussed in 
section 3.3.5, the maximum flow rate to ensure the complete mixing of glucose was calculated 
to be 5μL/min (total flow rate of inlet 1 and inlet 2) in the current system. Therefore, 5μL/min 
was used as the flow rate to characterise the sensing performance of this system. Under this 
condition, the characterised fluorescence profile for Ca2+ would serve as a good indicator to 
improve the chip design for biological applications in the future. 
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The detailed flow rate of each inlet and corresponding concentrations of Ca2+ and insulin are 
shown in Table 4.2. To measure the insulin via ELISA, a 1.5mL Eppendorf tube was placed 
under the tube, which was connected to the outlet (Fig. 4.2a). It is worth noting that a volume 
of 25μL is required for each sample. Considering the flow rate was 10μL/min at the outlet, the 
collecting time for each sample was 3 minutes to ensure a sufficient sample for the 
measurement. Therefore, the Eppendorf tube was replaced every three minutes.  
 





Flow Rate (μL/min) 
RI 
Inlet 1 Inlet 2 Inlet 3 Outlet 
0.2 10 4.5 0.5 5 10 9 : 1 
0.5 25 3.75 1.25 5 10 3 : 1 
1 50 2.5 2.5 5 10 1 : 1 
1.5 75 1.25 3.75 5 10 1 : 3 
1.8 90 0.5 4.5 5 10 1 : 9 
 
4.2.6 Quantification of insulin by direct sandwich ELISA 
The concentration of insulin was measured by an insulin ELISA kit (Mercodia, Sweden). The 
procedure is based on the direct sandwich technique, where two anti-insulin antibodies that 
bind to two separate antigenic sites on the insulin molecule. The experiment steps followed the 
protocol of the ELISA kit. Briefly, the effluents collected from the outlet of the chip every three 
minutes were used as the samples for the off-chip insulin quantification. In the 96-well 
microplate from the ELISA kit, the surface of each well was coated with anti-insulin antibody 
(primary antibody). Calibrators (standard samples with known concentrations of insulin), 
samples and peroxidase-conjugated anti-insulin antibodies (enzyme-conjugated secondary 
antibody) were successively added into the plate. The plate was then incubated for an hour to 
allow the binding between insulin and antibody, followed by a washing step to remove the 
unbound secondary antibody. To indicate the concentration of bound enzyme in the sample, 3, 
3’, 5, 5’-tetramethylbenzidine (TMD) (substrate) was added into the wells, where TMD reacted 
with the enzyme and the system turned from colourless to blue. A stop solution was added into 
the well to terminate the reaction to give a colourimetric endpoint. Subsequently, the 
absorbance of the samples was read at 450nm to calculate the concentration of insulin in the 





4.3.1 Standard curve of on-chip fluorescence intensity as a function of [Ca2+] 
To compare the off-chip measurements with on-chip results, the standard fluorescence curve 
in the microfluidic chip was plotted against the [Ca2+] together with the fluorescence measured 
in a microplate. 
As shown in Fig. 4.4, the profile of Rhod-5N in the microfluidic chip displayed a similar pattern 
in response to 0-2mM Ca2+ as the off-chip measurements, where significant fluorescence 
enhancements were observed in response to increasing [Ca2+] from 0-3mM. Consistent with 
the off-chip measurements, the on-chip fluorescent profile also well fitted in the ‘Hill fit’ 
analysis, which reflected the monomer binding between Rhod-5N and Ca2+. In addition, the 
minor standard deviations of the repeated on-chip measurements suggested a complete mixing 
and stable binding between Ca2+ and Rhod-5N at the optical window. The fluorescence curves 
show that the increase of off-chip fluorescence responding to 0.5-3mM Ca2+ was smaller than 
the increase of on-chip fluorescence. This tendency to saturation of the off-chip results may 
attribute to the fact that the Ca2+-induced fluorescence intensity of Rhod-5N was reaching the 
upper detection limit of the plate reader.    
 
 
Figure 4.4 | Comparison of on-chip (blue) and off-chip (red) fluorescence intensity of Rhod-5N as a 
function of Ca2+ concentration in the samples. The errors of the repeated measurement are significantly 
lower than the fluorescent signals, suggesting the highly stable flow rate over time and fluorescent sensing 




4.3.2 Oscillatory insulin concentrations in the artificial extracellular fluid 
Insulin concentrations in the effluents collected from the outlet (experiment 2) were measured 
by ELISA. As shown in Fig. 4.5a, OD values of the calibrators were plotted against the insulin 
concentration in the calibrators as the standard curve. The linear fit equation of the standard 
curve was then used to translate the OD values into corresponding concentrations of insulin in 
the effluent. As the concentration of insulin in the effluents represented the detecting 
concentration (indicated in Fig. 4.3), sample concentrations of the three groups were obtained 
by doubling the detecting concentration and shown in Fig. 4.5b. 
Oscillatory patterns of insulin concentration were recorded in the two groups with higher 
concentrations of insulin, 50-90mU/L and 25-75mU/L groups. However, the pattern was 
diminished in the lowest concentration group, where the insulin concentration should 
theoretically fluctuate between 10 and 50mU/L (Fig. 4.5b). Compared with the theoretical 
concentration (Fig. 4.5b, legend), the experimental results of the three groups were less than 
half of the concentration in theory. Therefore, the loss of the pattern could be caused by the 




Figure 4.5 | Quantification of sample concentrations of insulin collected from the outlet every 3 
minutes. a | Standard curve drawn with the OD and concentrations of the calibrators; b | Calculated sample 




4.3.3 Development of a dual-sensing system for simultaneous monitoring of [Ca2+]ex and 
insulin 
To demonstrate the dual-sensing capability of the system, the results of insulin quantification 
were integrated with the dynamic fluorescent signal recorded concurrently. As shown in Fig. 
4.6, the oscillatory patterns observed in insulin (Fig. 4.6, red) concentration synchronised with 
the dynamic fluorescence intensity (Fig. 4.6, blue) revealing the oscillating concentrations of 
Ca2+ (Fig. 4.6 top and middle). It was clear that one period of Ca2+ oscillation lasts around 500-
600s and the time required for the transition between two concentrations of Ca2+ is around 90s. 
When comparing the Ca2+-induced fluorescence and signal of insulin, a time delay of around 
70-100s was observed between the Ca2+ oscillation and corresponding insulin concentration. 
The time delay between the patterns of the two molecules reflected the time for the sample to 
travel from the optical window to the Eppendorf tube and also for the operations to change the 
flow rates. This time delay could be validated by calculating the volume (V) for the sample to 
travel through from the optical window to falcon tube. The distance from the optical window 
to the outlet (Lc) was 4000μm. Considering the channel width (300μm) and the height (250μm), 
the volume on-chip (Vc) was calculated as: 
𝑉𝑐 = 𝑤 × ℎ × 𝐿 
𝑉𝑐 = 300 × 250 × 4000 [𝜇𝑚
3] = 0.3𝜇𝐿 
As the length (Lt) and internal radius (ri) of the circular tube were 20cm and 0.25mm 
respectively, the volume in the tube (Vt) was expressed as: 
𝑉𝑡 = ᴨ𝑟𝑖
2𝐿𝑡 
𝑉𝑡 = ᴨ × 125
2 × 200000[𝜇𝑚3] ≈ 9.81 𝜇𝐿 





0.3 + 9.81 [𝜇𝐿]
10 [𝜇𝐿/𝑚𝑖𝑛]
= 60.675𝑠 
Therefore, the time delay observed between the insulin concentration and Ca2+-induced 
fluorescence resulted from the travelling time together with the operation time on adjusting the 
flow rate (10-20s). 
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In terms of signal strength, the highest fluorescent signal (around 60% of the maximum 
fluorescence) was observed as Ca2+ was oscillating between 0.2-1.0mM (Fig. 4.6 bottom). The 
corresponding signals were 40% and 20% in the 0.5-1.5mM group (Fig. 4.6 middle) and 1.0-
1.8mM group (Fig. 4.6 top), respectively. By continuously refreshing the indicator solution, 
the fluorescent signal in the microfluidic chip was free from drifting or photobleaching 
throughout the experiment period. 
 
 
Figure 4.6 | Simultaneous monitoring of Ca2+ and Insulin in biological samples via fluorescent sensing 
(blue) and ELISA (red). Both the [Ca2+] and insulin concentration were oscillating in the artificial 





This chapter demonstrated the feasibility of utilising the sensing system for simultaneous 
monitoring of [Ca2+]ex and insulin concentration in biological samples. The system, for the first 
time, successfully recorded the oscillatory [Ca2+] and insulin in an artificial extracellular 
environment based on cell culture medium. It was shown that the current temporal resolutions 
were 10 seconds on sensing Ca2+ and 3 minutes on quantifying insulin. While the system 
displayed a promising performance as a dual-sensing system, further improvements of the 
system should include reducing the loss of insulin, the automation of the procedure, mixing 
efficiency and temporal resolution.  
Firstly, the absorption of insulin by PDMS should be properly addressed so that minor 
fluctuation of insulin would be captured by the system. The blocking treatment conducted in 
this study was achieved by rinsed the channel with 0.3% BSA for 10 minutes. Strategies to 
enhance the exposure of the channel to BSA are likely to reduce the loss of insulin, such as 
increasing the concentration of BSA, continuously perfusing the channel with BSA solution 
instead of static treatment.    
Secondly, higher automation in flow rate control and sampling are in great demand to reduce 
the repeated operations, particularly in a long-term experiment. The establishment of the on-
chip standard curve of the fluorescence intensity as a function of [Ca2+] indicated the stability 
of the system, including the input control and fluorescence detection, over a relatively long 
experiment period (more than one hour). However, the laborious operations on flow rate 
adjustment and sample collection justified the necessity to introduce programs or devices that 
could enhance the degree of the automation of the system. For example, a pre-set flow rate 
schedule that spontaneously modifies the flow rates at a certain time point or an automated 
sample collector that automatically replaces the sample tube on the completion of a given 
sampling period. Moreover, manual operations significantly increased the time required for 
stabilising the signal. Therefore, improvement in the automation of the system will enhance 
the temporal resolution of the detection as well as the accuracy of the results.  
Last and most importantly, as the goal of developing this microfluidic sensing system was to 
investigate the role of [Ca2+]ex in the pulsatile insulin secretion, the temporal resolution of the 
system is expected to be higher than the periods of insulin pulsatility under physiological 
conditions (4-6 minutes 22). As the temporal resolution was faster than the periods of pulsatile 
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insulin secretion, the general insulin pulsatility would be recorded with the current sensing 
capability. However, it may fail to genuinely reveal the occurrence of fast oscillations which 
oscillate at a shorter period (~4 minutes). 
Therefore, the temporal resolution of the platform should be optimised further. One solution is 
to enhance the mixing efficiency of the microfluidic chip so that higher flow rates can be 
applied on the system, allowing to collect the sample for insulin detection within a shorter 
period of time. As a result, the interval between each measurement would be reduced, leading 
to a higher temporal resolution on insulin quantification. Passive mixers, such as herringbones 
structure 231, are promising candidates to be embedded into the microfluidic channel as they 
effectively enhance the mixing efficiency without the assistance of external device 232.  
Alternatively, on-chip insulin quantification via capillary electrophoresis immunoassay (CEI) 
is also a reliable technique to be incorporated into the system 160,165,178,233. Similar to the 
competitive ELISA, on-chip CEI is based on competitive binding between insulin in the 
samples and fluorescein isothiocyanate-labelled insulin (FITC-insulin) to the anti-insulin 
antibody (Ab). In a microfluidic chip, the effluent from a pancreatic islet, Ab and FITC-insulin 
are individually pumped into a reaction channel, where insulin in the effluent and FITC-insulin 
competitively bind to Ab. The reacted mixture is then injected into an electrophoresis channel, 
where the bound and unbound FITC-insulin are separated due to their different velocity in the 
electric field (unbound FITC-insulin would be faster as they are lighter). Since the ratio of 
bound to unbound FITC-insulin is dependent on the concentration of insulin from the islet, the 
insulin secretion can be quantified by comparing the fluorescence of bound and unbound FITC-
insulin as they successively pass through the detection point. By integrating the on-chip CEI, 
a real-time dual-sensing system can be achieved with temporal resolutions of tens of seconds 
on both [Ca2+]ex and insulin secretion. However, as CEI demands another independent LIF 
detection system, which significantly complicates the experimental setup. Further evaluation 











Conclusions & Perspectives 
 
The work detailed in this thesis relates to the development of a novel microfluidic sensing 
platform capable of simultaneous monitoring of extracellular Ca2+ and insulin, which will 
enable thorough investigation on the role of Ca2+ in insulin secretion from the endocrine 
pancreas.  
As described in Chapter 1, Ca2+ is involved in a complex intracellular and extracellular 
signalling pathways responsible for insulin secretion from the pancreatic islets, which plays a 
central role in maintaining blood glucose homeostasis in health. The disrupted insulin secretion, 
characterised as both impaired responsiveness of the pancreatic beta-cells to glucose 
stimulation and the pulsative secretory pattern, has featured early pathophysiology of T2DM, 
one of the most devastating chronic diseases in the modern society. The current understanding 
relating to the dynamic [Ca2+] and the physiology of insulin secretion has been facilitated by 
the development of novel Ca2+ sensors. In particular, the role of intracellular Ca2+ signalling 
has been clarified using synthetic fluorescent indicators. However, the mechanism of 
extracellular Ca2+ signalling pathway is poorly defined due to the lack of sensing method 
suitable for measurement of both dynamic [Ca2+]ex and insulin secretion from the pancreatic 
islets. Therefore, the fundamental aim of the work in this thesis was to overcome this barrier 
by developing a novel microfluidic sensing system that is capable of sensing [Ca2+]ex and 
insulin secretion from tissues simultaneously.  
In Chapter 2, quantitative methods for determining [Ca2+]ex were established based on 
commercially available fluorescent indicators, Calcein and Rhod-5N 
63,74. Although previous 
studies suggested that these two fluorescent indicators might be suitable candidates, systematic 
evaluations relating to their performance in sensing [Ca2+]ex, including the fluorescent profile, 
selectivity and compatibility with the biological system, have not been reported. The two 
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methods presented in this work exhibited comparable or even superior capabilities to those 
recently developed methods for measuring [Ca2+]ex 
179-181. Furthermore, the environment-
dependent selectivity of Calcein and the effect of Zn2+ and Cu2+ on Rhod-5N justified the 
necessity to investigate the interference from the other metal ions in the proposed working 
environment. As a conclusion of this chapter, Rhod-5N was more suitable for tracking dynamic 
[Ca2+]ex considering its higher signal to background ratio and the compatibility with the 
biological environment. 
In Chapter 3, a microfluidic chip was designed, fabricated and characterised for correlating the 
dynamic [Ca2+]ex with the function of the tissue. The current measurement for [Ca
2+]ex relies 
on the CSM 129, which intrinsically reflects the dynamic [Ca2+]ex in proximity to a single cell. 
Considering the broad roles of [Ca2+]ex in multi-cellular level, the applicability of ISM is 
limited when correlating [Ca2+]ex and the tissue function, such as the secretion of insulin from 
the pancreatic islets. With the microfluidic described in this work, tissue culture, dynamic 
stimulation and functional analysis were performed with one experiment set up. The continuous 
extraction of extracellular fluid would allow simultaneous examination of [Ca2+]ex and insulin 
secretion in the effluent. Due to the limited mixing efficiency, the maximum on-chip flow rate 
is relatively smaller compared with other chip devices for secretion analysis, where the on-chip 
flow rate ranges from tens to a hundred microliter per minute 234. Therefore, future work should 
consider the incorporation of the efficient fluid mixer, such as the herringbones structure, to 
enhance a higher mixing efficiency and, therefore, allow a higher flow rate in the microfluidic 
channel 231. A novel, but logical extension from the islet study, the development of different 
tissue trapping structures may enable evaluation of the endocrine function of tissues other than 
islets.   
 
Hitherto, the microfluidic device developed for islet study have been focusing on the dynamic 
intracellular Ca2+ and insulin secretion 150,151.  In Chapter 4, a series of “proof-of-concept” 
experiments have shown the competency of the microfluidic sensing platform as a dual-sensing 
system for simultaneous monitoring of [Ca2+]ex and insulin in biological samples. The 
development of this novel sensing platform is likely to substantially advance the understanding 
of the mechanisms underlying insulin secretion, although several limitations, including the 
time delay between the signals for [Ca2+] and insulin, temporal resolution for insulin 
quantification and the potential diffusion of insulin out of the flow, remain to be optimised. 
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In summary, this thesis has established a novel sensing platform capable of concurrent 
monitoring of [Ca2+]ex and insulin, which has the potential to advance the understanding of the 
(patho-)physiology of the pancreatic islets. The possibility of functionalising the microfluidic 
system into a multiplexed sensor renders the customised applications of the system for a variety 
of biological research in the future. For example, fluorescent indicators can be introduced into 
cells of the tissue to track the dynamics of intracellular biomarkers so that the correlation 
between the intracellular and the extracellular signalling would be established. Moreover, 
multi-targets measurements can be achieved by the simultaneous loading of fluorescent 
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